<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26170503</article-id><article-id pub-id-type="pmc">4490813</article-id><article-id pub-id-type="publisher-id">BLT.14.147215</article-id><article-id pub-id-type="doi">10.2471/BLT.14.147215</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>A comparative analysis of national HIV policies in six African countries with generalized epidemics</article-title><trans-title-group xml:lang="fr"><trans-title xml:lang="fr">Analyse comparative des politiques nationales de lutte contre le VIH dans six pays africains o&#x000f9; l'&#x000e9;pid&#x000e9;mie est g&#x000e9;n&#x000e9;ralis&#x000e9;e</trans-title></trans-title-group><trans-title-group xml:lang="es"><trans-title xml:lang="es">Un an&#x000e1;lisis comparativo de las pol&#x000ed;ticas nacionales sobre el VIH en seis pa&#x000ed;ses africanos con epidemias generalizadas</trans-title></trans-title-group><trans-title-group xml:lang="ar"><trans-title xml:lang="ar"><bold/>&#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644; &#x00645;&#x00642;&#x00627;&#x00631;&#x00646; &#x00644;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00648;&#x00637;&#x00646;&#x0064a;&#x00629; &#x00645;&#x00643;&#x00627;&#x00641;&#x0062d;&#x00629; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x00639;&#x00648;&#x00632; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00639;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00634;&#x00631;&#x0064a; &#x00641;&#x0064a; &#x00633;&#x0062a;&#x00629; &#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00623;&#x00641;&#x00631;&#x0064a;&#x00642;&#x0064a;&#x00629;&#x000a0;&#x0062a;&#x00639;&#x00627;&#x00646;&#x0064a;&#x000a0;&#x00645;&#x00646;&#x000a0;&#x00623;&#x00648;&#x00628;&#x00626;&#x00629;&#x000a0;&#x00645;&#x00639;&#x00645;&#x00645;&#x00629; </trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title xml:lang="zh"> &#x05728;&#x0827e;&#x06ecb;&#x075c5;&#x075c5;&#x06bd2;&#x05e7f;&#x06cdb;&#x06d41;&#x0884c;&#x07684;&#x0516d;&#x04e2a;&#x0975e;&#x06d32;&#x056fd;&#x05bb6;&#x04e2d;&#x05f00;&#x05c55;&#x05173;&#x04e8e;&#x056fd;&#x05bb6;&#x0827e;&#x06ecb;&#x075c5;&#x075c5;&#x06bd2;&#x0653f;&#x07b56;&#x07684;&#x05bf9;&#x06bd4;&#x05206;&#x06790;</trans-title></trans-title-group><trans-title-group xml:lang="ru"><trans-title xml:lang="ru">&#x00421;&#x00440;&#x00430;&#x00432;&#x0043d;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437; &#x00433;&#x0043e;&#x00441;&#x00443;&#x00434;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a;&#x00438; &#x00432; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00438; &#x00412;&#x00418;&#x00427; &#x00432; &#x00448;&#x00435;&#x00441;&#x00442;&#x00438; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00410;&#x00444;&#x00440;&#x00438;&#x0043a;&#x00438; &#x00441; &#x00433;&#x00435;&#x0043d;&#x00435;&#x00440;&#x00430;&#x0043b;&#x00438;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x0044d;&#x0043f;&#x00438;&#x00434;&#x00435;&#x0043c;&#x00438;&#x00435;&#x00439;</trans-title></trans-title-group><alt-title alt-title-type="author-running-head">Kathryn Church et al.</alt-title><alt-title alt-title-type="title-running-head">HIV policies in Africa</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Church</surname><given-names>Kathryn</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kiweewa</surname><given-names>Francis</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dasgupta</surname><given-names>Aisha</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mwangome</surname><given-names>Mary</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mpandaguta</surname><given-names>Edith</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>G&#x000f3;mez-Oliv&#x000e9;</surname><given-names>Francesc Xavier</given-names></name><xref ref-type="aff" rid="aff5"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Oti</surname><given-names>Samuel</given-names></name><xref ref-type="aff" rid="aff6"><sup>f</sup></xref></contrib><contrib contrib-type="author"><name><surname>Todd</surname><given-names>Jim</given-names></name><xref ref-type="aff" rid="aff7"><sup>g</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wringe</surname><given-names>Alison</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Geubbels</surname><given-names>Eveline</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Crampin</surname><given-names>Amelia</given-names></name><xref ref-type="aff" rid="aff7"><sup>g</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nakiyingi-Miiro</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="aff8"><sup>h</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hayashi</surname><given-names>Chika</given-names></name><xref ref-type="aff" rid="aff9"><sup>i</sup></xref></contrib><contrib contrib-type="author"><name><surname>Njage</surname><given-names>Muthoni</given-names></name><xref ref-type="aff" rid="aff10"><sup>j</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wagner</surname><given-names>Ryan G</given-names></name><xref ref-type="aff" rid="aff5"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ario</surname><given-names>Alex Riolexus</given-names></name><xref ref-type="aff" rid="aff11"><sup>k</sup></xref></contrib><contrib contrib-type="author"><name><surname>Makombe</surname><given-names>Simon D</given-names></name><xref ref-type="aff" rid="aff12"><sup>l</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mugurungi</surname><given-names>Owen</given-names></name><xref ref-type="aff" rid="aff13"><sup>m</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zaba</surname><given-names>Basia</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label>a</label>Department of Population Health, London School of Hygiene &#x00026; Tropical Medicine, Keppel St, London, WC1E 7HT, <country>England</country>.</aff><aff id="aff2"><label>b</label>Makerere University School of Public Health, Kampala, <country>Uganda</country>.</aff><aff id="aff3"><label>c</label>Ifakara Health Institute, Ifakara, United Republic of <country>Tanzania</country>.</aff><aff id="aff4"><label>d</label>Manicaland HIV/STD Prevention Project, Harare, <country>Zimbabwe</country>.</aff><aff id="aff5"><label>e</label>Agincourt, Rural Public Health and Health Transitions Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, <country>South Africa</country>.</aff><aff id="aff6"><label>f</label>African Population Health Research Center, Nairobi, <country>Kenya</country>.</aff><aff id="aff7"><label>g</label>London School of Hygiene &#x00026; Tropical Medicine, London, <country>England</country>.</aff><aff id="aff8"><label>h</label>MRC/UVRI Uganda Research Unit on HIV/AIDS, Entebbe, <country>Uganda</country>.</aff><aff id="aff9"><label>i</label>World Health Organization, Geneva, <country>Switzerland</country>.</aff><aff id="aff10"><label>j</label>Consultant, Nairobi, <country>Kenya</country>.</aff><aff id="aff11"><label>k</label>Ministry of Health, Kampala, <country>Uganda</country>.</aff><aff id="aff12"><label>l</label>Ministry of Health, Lilongwe, <country>Malawi</country>.</aff><aff id="aff13"><label>m</label>Ministry of Health and Child Care, Harare, <country>Zimbabwe</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Kathryn Church (email: <email xlink:href="kathryn.church@lshtm.ac.uk">kathryn.church@lshtm.ac.uk</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>7</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>28</day><month>4</month><year>2015</year></pub-date><volume>93</volume><issue>7</issue><fpage>457</fpage><lpage>467</lpage><history><date date-type="received"><day>11</day><month>9</month><year>2014</year></date><date date-type="rev-recd"><day>16</day><month>12</month><year>2014</year></date><date date-type="accepted"><day>23</day><month>1</month><year>2015</year></date></history><permissions><copyright-statement>(c) 2015 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.</license-p></license></permissions><abstract><title>Abstract</title><sec><title>Objective</title><p>To compare national human immunodeficiency virus (HIV) policies influencing access to HIV testing and treatment services in six sub-Saharan African countries.</p></sec><sec><title>Methods</title><p>We reviewed HIV policies as part of a multi-country study on adult mortality in sub-Saharan Africa. A policy extraction tool was developed and used to review national HIV policy documents and guidelines published in Kenya, Malawi, South Africa, Uganda, the United Republic of Tanzania and Zimbabwe between 2003 and 2013. Key informant interviews helped to fill gaps in findings. National policies were categorized according to whether they explicitly or implicitly adhered to 54 policy indicators, identified through literature and expert reviews. We also compared the national policies with World Health Organization (WHO) guidance.</p></sec><sec><title>Findings</title><p>There was wide variation in policies between countries; each country was progressive in some areas and not in others. Malawi was particularly advanced in promoting rapid initiation of antiretroviral therapy. However, no country had a consistently enabling policy context expected to increase access to care and prevent attrition. Countries went beyond WHO guidance in certain areas and key informants reported that practice often surpassed policy.</p></sec><sec><title>Conclusion</title><p>Evaluating the impact of policy differences on access to care and health outcomes among people living with HIV is challenging. Certain policies will exert more influence than others and official policies are not always implemented. Future research should assess the extent of policy implementation and link these findings with HIV outcomes.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><sec><title>Objectif</title><p>Comparer les politiques nationales de lutte contre le virus de l'immunod&#x000e9;ficience humaine (VIH) qui influencent l'acc&#x000e8;s aux services de d&#x000e9;pistage et de traitement du VIH dans six pays d'Afrique subsaharienne.</p></sec><sec><title>M&#x000e9;thodes</title><p>Nous avons examin&#x000e9; les politiques de lutte contre le VIH dans le cadre d'une &#x000e9;tude multi-pays sur la mortalit&#x000e9; des adultes en Afrique subsaharienne. Un outil d'extraction de donn&#x000e9;es a &#x000e9;t&#x000e9; mis au point et utilis&#x000e9; afin d'examiner les documents et les directives des politiques nationales de lutte contre le VIH publi&#x000e9;s en Afrique du Sud, au Kenya, au Malawi, en Ouganda, en R&#x000e9;publique-Unie de Tanzanie et au Zimbabwe entre 2003 et 2013. Des entretiens avec des informateurs cl&#x000e9;s ont permis de combler les carences de ces r&#x000e9;sultats. Les politiques nationales ont &#x000e9;t&#x000e9; class&#x000e9;es suivant leur degr&#x000e9; de correspondance, explicite ou implicite, avec 54&#x000a0;indicateurs relatifs aux politiques, d&#x000e9;termin&#x000e9;s d'apr&#x000e8;s des analyses documentaires et des examens d'experts. Nous avons &#x000e9;galement compar&#x000e9; les politiques nationales avec les recommandations de l'Organisation mondiale de la Sant&#x000e9; (OMS).</p></sec><sec><title>R&#x000e9;sultats</title><p>Nous avons observ&#x000e9; de grandes diff&#x000e9;rences entre les politiques de ces pays&#x000a0;; chaque pays &#x000e9;tait avanc&#x000e9; dans certains domaines et pas dans d'autres. Le Malawi l'&#x000e9;tait particuli&#x000e8;rement en mati&#x000e8;re de promotion du d&#x000e9;marrage rapide du traitement antir&#x000e9;troviral. Cependant, aucun pays n'avait un contexte politique pouvant syst&#x000e9;matiquement permettre d'augmenter l'acc&#x000e8;s aux soins et d'&#x000e9;viter l'arr&#x000ea;t du traitement. Dans certains domaines, les pays allaient plus loin que les recommandations de l'OMS et les informateurs ont indiqu&#x000e9; que la pratique d&#x000e9;passait souvent le cadre des politiques.</p></sec><sec><title>Conclusion</title><p>&#x000c9;valuer l'impact des diff&#x000e9;rentes politiques sur l'acc&#x000e8;s aux soins et les r&#x000e9;sultats en termes de sant&#x000e9; des personnes qui vivent avec le VIH n'est pas chose simple. Certaines politiques exercent une influence plus forte que d'autres et les politiques officielles ne sont pas toujours mises en &#x00153;uvre. Des recherches ult&#x000e9;rieures devraient &#x000e9;valuer le degr&#x000e9; de mise en &#x00153;uvre des politiques et mettre en lien leurs conclusions avec les r&#x000e9;sultats de la lutte contre le VIH.</p></sec></trans-abstract><trans-abstract xml:lang="es"><title>Resumen</title><sec><title>Objetivo</title><p>Comparar las pol&#x000ed;ticas nacionales relativas al virus de la inmunodeficiencia humana (VIH) que influencian el acceso a las pruebas del VIH y a los tratamientos en seis pa&#x000ed;ses sub-saharianos.</p></sec><sec><title>M&#x000e9;todos</title><p>Se revisaron las pol&#x000ed;ticas relativas al VIH como parte de un estudio multinacional sobre la mortalidad de adultos en &#x000c1;frica Subsahariana. Se desarroll&#x000f3; una herramienta de extracci&#x000f3;n de pol&#x000ed;ticas y se utiliz&#x000f3; para revisar los documentos y gu&#x000ed;as de las pol&#x000ed;ticas nacionales relativas al VIH publicadas en Kenia, Malawi, Rep&#x000fa;blica Unida de Tanzania, Sud&#x000e1;frica, Uganda y Zimbabue entre 2003 y 2013. Se hicieron entrevistas a informantes claves que ayudaron a llenar los vac&#x000ed;os en los resultados. Las pol&#x000ed;ticas nacionales se clasificaron seg&#x000fa;n si se adhirieron expl&#x000ed;cita o impl&#x000ed;citamente a 54 indicadores de pol&#x000ed;ticas, identificados mediante bibliograf&#x000ed;a y opiniones de expertos. Asimismo, se compararon las pol&#x000ed;ticas nacionales con las directrices de la Organizaci&#x000f3;n Mundial de la Salud (OMS).</p></sec><sec><title>Resultados</title><p>Se descubri&#x000f3; que hab&#x000ed;a una amplia variedad entre las pol&#x000ed;ticas de los pa&#x000ed;ses. Cada pa&#x000ed;s estaba m&#x000e1;s avanzado en algunas &#x000e1;reas que en otras. Malawi estaba especialmente avanzado en la promoci&#x000f3;n de empezar r&#x000e1;pidamente la terapia antirretroviral. Sin embargo, ning&#x000fa;n pa&#x000ed;s ten&#x000ed;a un contexto de introducci&#x000f3;n de pol&#x000ed;ticas consistente que incrementara el acceso a la atenci&#x000f3;n primaria y evitara la deserci&#x000f3;n. Algunos pa&#x000ed;ses iban m&#x000e1;s all&#x000e1; de las orientaciones de la OMS en algunas &#x000e1;reas e informantes clave informaron de que la pr&#x000e1;ctica a menudo superaba la pol&#x000ed;tica.</p></sec><sec><title>Conclusi&#x000f3;n</title><p>Evaluar el impacto de las diferencias en las pol&#x000ed;ticas relativas en el acceso a la atenci&#x000f3;n primaria y los resultados en la salud entre aquellas personas con VIH es un reto. Algunas pol&#x000ed;ticas ejercer&#x000e1;n m&#x000e1;s influencia que otras y las pol&#x000ed;ticas oficiales no siempre se aplican. Las investigaciones futuras deber&#x000ed;an evaluar el grado de aplicaci&#x000f3;n de las pol&#x000ed;ticas y vincular estos resultados con los resultados del VIH.</p></sec></trans-abstract><trans-abstract xml:lang="ar"><title>&#x00645;&#x00644;&#x0062e;&#x00635; </title><p>&#x00627;&#x00644;&#x0063a;&#x00631;&#x00636; <bold>: </bold> &#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629; &#x00627;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00648;&#x00637;&#x00646;&#x0064a;&#x00629; &#x00644;&#x00645;&#x00643;&#x00627;&#x00641;&#x0062d;&#x00629; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x00639;&#x00648;&#x00632; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00639;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00634;&#x00631;&#x0064a;(HIV) &#x00648;&#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00624;&#x0062b;&#x00631; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00642;&#x0062f;&#x00631;&#x00629; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00641;&#x00627;&#x0062f;&#x00629; &#x00645;&#x00646; &#x0062e;&#x0062f;&#x00645;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631; &#x00648;&#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00645;&#x00646; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x00639;&#x00648;&#x00632; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00639;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00634;&#x00631;&#x0064a; &#x00641;&#x0064a; &#x00633;&#x0062a;&#x00629; &#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00623;&#x00641;&#x00631;&#x0064a;&#x00642;&#x0064a;&#x00629; &#x00648;&#x00627;&#x00642;&#x00639;&#x00629; &#x0062c;&#x00646;&#x00648;&#x00628;&#x0064a; &#x00627;&#x00644;&#x00635;&#x0062d;&#x00631;&#x00627;&#x00621;. </p><p>&#x00627;&#x00644;&#x00637;&#x00631;&#x0064a;&#x00642;&#x00629; <bold>: </bold> &#x00644;&#x00642;&#x0062f; &#x00631;&#x00627;&#x0062c;&#x00639;&#x00646;&#x00627; &#x00633;&#x0064a;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00645;&#x00643;&#x00627;&#x00641;&#x0062d;&#x00629; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x00639;&#x00648;&#x00632; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00639;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00634;&#x00631;&#x0064a; &#x00643;&#x0062c;&#x00632;&#x00621; &#x00645;&#x00646; &#x0062f;&#x00631;&#x00627;&#x00633;&#x00629; &#x00634;&#x00645;&#x00644;&#x0062a; &#x00627;&#x00644;&#x00639;&#x0062f;&#x0064a;&#x0062f; &#x00645;&#x00646; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x0062d;&#x00648;&#x00644; &#x00645;&#x00639;&#x0062f;&#x00644;&#x00627;&#x0062a; &#x00648;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00628;&#x00627;&#x00644;&#x0063a;&#x0064a;&#x00646; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00627;&#x00644;&#x00623;&#x00641;&#x00631;&#x0064a;&#x00642;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00648;&#x00627;&#x00642;&#x00639;&#x00629; &#x0062c;&#x00646;&#x00648;&#x00628;&#x0064a; &#x00627;&#x00644;&#x00635;&#x0062d;&#x00631;&#x00627;&#x00621;. &#x0062a;&#x00645; &#x00625;&#x00639;&#x0062f;&#x00627;&#x0062f; &#x00648;&#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00623;&#x0062f;&#x00627;&#x00629; &#x00627;&#x00633;&#x0062a;&#x0062e;&#x00644;&#x00627;&#x00635; &#x00627;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00629; &#x00644;&#x00645;&#x00631;&#x00627;&#x0062c;&#x00639;&#x00629; &#x00627;&#x00644;&#x00648;&#x0062b;&#x00627;&#x00626;&#x00642; &#x00648;&#x00627;&#x00644;&#x00645;&#x00628;&#x00627;&#x0062f;&#x00626; &#x00627;&#x00644;&#x0062a;&#x00648;&#x0062c;&#x0064a;&#x00647;&#x0064a;&#x00629; &#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00629; &#x00645;&#x00643;&#x00627;&#x00641;&#x0062d;&#x00629; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x00639;&#x00648;&#x00632; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00639;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00634;&#x00631;&#x0064a; &#x00627;&#x00644;&#x00648;&#x00637;&#x00646;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x00646;&#x00634;&#x00631;&#x0062a; &#x00641;&#x0064a; &#x00643;&#x0064a;&#x00646;&#x0064a;&#x00627; &#x00648;&#x00645;&#x00644;&#x00627;&#x00648;&#x0064a; &#x00648;&#x0062c;&#x00646;&#x00648;&#x00628; &#x00623;&#x00641;&#x00631;&#x0064a;&#x00642;&#x0064a;&#x00627; &#x00648;&#x00623;&#x00648;&#x0063a;&#x00646;&#x0062f;&#x00627; &#x00648;&#x0062c;&#x00645;&#x00647;&#x00648;&#x00631;&#x0064a;&#x00629; &#x0062a;&#x00646;&#x00632;&#x00627;&#x00646;&#x0064a;&#x00627; &#x00627;&#x00644;&#x00645;&#x0062a;&#x0062d;&#x0062f;&#x00629; &#x00648;&#x00632;&#x00645;&#x00628;&#x00627;&#x00628;&#x00648;&#x0064a; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00641;&#x0062a;&#x00631;&#x00629; &#x00645;&#x00627; &#x00628;&#x0064a;&#x00646; &#x00639;&#x00627;&#x00645;&#x000a0;2003&#x000a0;&#x00648;2013. &#x00648;&#x00644;&#x00642;&#x0062f; &#x00633;&#x00627;&#x00639;&#x0062f;&#x0062a; &#x00645;&#x00642;&#x00627;&#x00628;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00628;&#x00644;&#x00651;&#x0063a;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00631;&#x00626;&#x0064a;&#x00633;&#x0064a;&#x00646; &#x00639;&#x00644;&#x00649; &#x00633;&#x0062f; &#x00627;&#x00644;&#x0062b;&#x0063a;&#x00631;&#x00627;&#x0062a; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c;. &#x00635;&#x0064f;&#x00646;&#x00651;&#x00650;&#x00641;&#x0062a; &#x00627;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00648;&#x00637;&#x00646;&#x0064a;&#x00629; &#x00648;&#x00641;&#x00642;&#x0064b;&#x00627; &#x00644;&#x00645;&#x00627; &#x00625;&#x00630;&#x00627; &#x00643;&#x00627;&#x00646;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x00632;&#x00645;&#x0062a; &#x00635;&#x00631;&#x00627;&#x0062d;&#x00629;&#x0064b; &#x00623;&#x00648; &#x00636;&#x00645;&#x00646;&#x0064a;&#x0064b;&#x00627; &#x00628;&#x00640;&#x000a0;54 &#x00645;&#x00646; &#x00645;&#x00624;&#x00634;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00629;&#x0060c; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00645; &#x0062a;&#x0062d;&#x0062f;&#x0064a;&#x0062f;&#x00647;&#x00627; &#x00645;&#x00646; &#x0062e;&#x00644;&#x00627;&#x00644; &#x00627;&#x00644;&#x00645;&#x00624;&#x00644;&#x00641;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00637;&#x00628;&#x0064a;&#x00629; &#x00648;&#x00645;&#x00631;&#x00627;&#x0062c;&#x00639;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062e;&#x00628;&#x00631;&#x00627;&#x00621;. &#x00648;&#x00642;&#x00645;&#x00646;&#x00627; &#x00623;&#x0064a;&#x00636;&#x0064b;&#x00627; &#x00628;&#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629; &#x00627;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00648;&#x00637;&#x00646;&#x0064a;&#x00629; &#x00645;&#x00639; &#x0062a;&#x00648;&#x0062c;&#x0064a;&#x00647;&#x00627;&#x0062a; &#x00645;&#x00646;&#x00638;&#x00645;&#x00629; &#x00627;&#x00644;&#x00635;&#x0062d;&#x00629; &#x00627;&#x00644;&#x00639;&#x00627;&#x00644;&#x00645;&#x0064a;&#x00629; (WHO). </p><p>&#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; <bold>: </bold> &#x00643;&#x00627;&#x00646; &#x00647;&#x00646;&#x00627;&#x00643; &#x0062a;&#x00641;&#x00627;&#x00648;&#x0062a; &#x00643;&#x00628;&#x0064a;&#x00631; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646;&#x0061b; &#x0062d;&#x0064a;&#x0062b; &#x0062a;&#x00645;&#x0064a;&#x00632; &#x00643;&#x00644; &#x00628;&#x00644;&#x0062f; &#x00628;&#x00627;&#x00644;&#x0062a;&#x00642;&#x0062f;&#x00645; &#x00641;&#x0064a; &#x00628;&#x00639;&#x00636; &#x00627;&#x00644;&#x0062c;&#x00648;&#x00627;&#x00646;&#x00628; &#x0062f;&#x00648;&#x00646; &#x0063a;&#x0064a;&#x00631;&#x00647;&#x00627;. &#x00643;&#x00627;&#x00646;&#x0062a; &#x00645;&#x00644;&#x00627;&#x00648;&#x0064a; &#x00645;&#x0062a;&#x00642;&#x0062f;&#x00645;&#x00629; &#x00639;&#x00644;&#x00649; &#x00648;&#x0062c;&#x00647; &#x00627;&#x00644;&#x0062e;&#x00635;&#x00648;&#x00635; &#x00641;&#x0064a; &#x0062a;&#x00639;&#x00632;&#x0064a;&#x00632; &#x00641;&#x00643;&#x00631;&#x00629; &#x00627;&#x00644;&#x00625;&#x00633;&#x00631;&#x00627;&#x00639; &#x00641;&#x0064a; &#x00628;&#x0062f;&#x00621; &#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00628;&#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x00647;&#x00642;&#x00631;&#x0064a;&#x00629;. &#x00648;&#x00645;&#x00639; &#x00630;&#x00644;&#x00643;&#x0060c; &#x00644;&#x00645; &#x0064a;&#x00643;&#x00646; &#x00644;&#x0062f;&#x00649; &#x00623;&#x0064a; &#x00628;&#x00644;&#x0062f; &#x00633;&#x0064a;&#x00627;&#x00642; &#x00644;&#x0062a;&#x00637;&#x00628;&#x0064a;&#x00642; &#x00633;&#x0064a;&#x00627;&#x00633;&#x00629; &#x0062a;&#x0062a;&#x0064a;&#x0062d; &#x0062a;&#x00637;&#x00648;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00642;&#x0062f;&#x00631;&#x00627;&#x0062a; &#x00628;&#x00635;&#x00648;&#x00631;&#x00629; &#x0062b;&#x00627;&#x00628;&#x0062a;&#x00629;&#x0060c; &#x00628;&#x0062d;&#x0064a;&#x0062b; &#x0064a;&#x0064f;&#x00646;&#x0062a;&#x00638;&#x00631; &#x00645;&#x00646;&#x00647; &#x0062a;&#x0064a;&#x00633;&#x0064a;&#x00631; &#x00633;&#x00628;&#x00644; &#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00641;&#x00627;&#x0062f;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x00631;&#x00639;&#x00627;&#x0064a;&#x00629; &#x00648;&#x00627;&#x00644;&#x0062d;&#x0062f; &#x00645;&#x00646; &#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00646;&#x00632;&#x00627;&#x00641;. &#x00642;&#x00627;&#x00645;&#x0062a; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00628;&#x0062a;&#x0062c;&#x00627;&#x00648;&#x00632; &#x0062a;&#x00648;&#x0062c;&#x0064a;&#x00647;&#x00627;&#x0062a; &#x00645;&#x00646;&#x00638;&#x00645;&#x00629; &#x00627;&#x00644;&#x00635;&#x0062d;&#x00629; &#x00627;&#x00644;&#x00639;&#x00627;&#x00644;&#x00645;&#x0064a;&#x00629; &#x00641;&#x0064a; &#x00645;&#x00646;&#x00627;&#x00637;&#x00642; &#x00645;&#x00639;&#x0064a;&#x00646;&#x00629; &#x00648;&#x00630;&#x00643;&#x00631; &#x00627;&#x00644;&#x00645;&#x00628;&#x00644;&#x00651;&#x0063a;&#x00648;&#x00646; &#x00627;&#x00644;&#x00631;&#x00626;&#x0064a;&#x00633;&#x00648;&#x00646; &#x00623;&#x00646; &#x00627;&#x00644;&#x00645;&#x00645;&#x00627;&#x00631;&#x00633;&#x00629; &#x0063a;&#x00627;&#x00644;&#x00628;&#x0064b;&#x00627; &#x00645;&#x00627; &#x00643;&#x00627;&#x00646;&#x0062a; &#x0062a;&#x0062a;&#x0062c;&#x00627;&#x00648;&#x00632; &#x00627;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00629;. </p><p>&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00646;&#x0062a;&#x00627;&#x0062c; <bold>: </bold> &#x00645;&#x00646; &#x00627;&#x00644;&#x00639;&#x00633;&#x0064a;&#x00631; &#x0062a;&#x00642;&#x0064a;&#x0064a;&#x00645; &#x0062a;&#x00623;&#x0062b;&#x0064a;&#x00631; &#x00627;&#x0062e;&#x0062a;&#x00644;&#x00627;&#x00641;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00629; &#x00641;&#x0064a; &#x00641;&#x00631;&#x00635; &#x00627;&#x00644;&#x0062d;&#x00635;&#x00648;&#x00644; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00631;&#x00639;&#x00627;&#x0064a;&#x00629; &#x00648;&#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00627;&#x00644;&#x00635;&#x0062d;&#x0064a;&#x00629; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00623;&#x00634;&#x0062e;&#x00627;&#x00635; &#x00627;&#x00644;&#x00645;&#x00635;&#x00627;&#x00628;&#x0064a;&#x00646; &#x00628;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x00639;&#x00648;&#x00632; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00639;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00634;&#x00631;&#x0064a;. &#x00641;&#x00633;&#x00648;&#x00641; &#x0062a;&#x0062d;&#x00642;&#x00642; &#x00628;&#x00639;&#x00636; &#x00627;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00639;&#x0064a;&#x00646;&#x00629; &#x00627;&#x00644;&#x00645;&#x00632;&#x0064a;&#x0062f; &#x00645;&#x00646; &#x00627;&#x00644;&#x0062a;&#x00623;&#x0062b;&#x0064a;&#x00631; &#x0062f;&#x00648;&#x00646; &#x00633;&#x00648;&#x00627;&#x00647;&#x00627;&#x0060c; &#x00643;&#x00645;&#x00627; &#x00644;&#x00627; &#x0064a;&#x0062a;&#x00645; &#x0062f;&#x00627;&#x00626;&#x00645;&#x0064b;&#x00627; &#x0062a;&#x00646;&#x00641;&#x0064a;&#x00630; &#x00627;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00631;&#x00633;&#x00645;&#x0064a;&#x00629;. &#x0064a;&#x00646;&#x00628;&#x0063a;&#x0064a; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00623;&#x00628;&#x0062d;&#x00627;&#x0062b; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00642;&#x00628;&#x00644;&#x0064a;&#x00629; &#x0062a;&#x00642;&#x0064a;&#x0064a;&#x00645; &#x00645;&#x0062f;&#x00649; &#x0062a;&#x00646;&#x00641;&#x0064a;&#x00630; &#x00627;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00648;&#x00631;&#x00628;&#x00637; &#x00647;&#x00630;&#x00647; &#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00628;&#x0062d;&#x00635;&#x00627;&#x00626;&#x00644; &#x00627;&#x00644;&#x00625;&#x00635;&#x00627;&#x00628;&#x00629; &#x00628;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x00639;&#x00648;&#x00632; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00639;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00634;&#x00631;&#x0064a;. </p></trans-abstract><trans-abstract xml:lang="zh"><title>&#x06458;&#x08981;</title><sec><title>&#x076ee;&#x07684;</title><p>&#x065e8;&#x05728;&#x05bf9;&#x06bd4;&#x05728;&#x06492;&#x054c8;&#x062c9;&#x06c99;&#x06f20;&#x04ee5;&#x05357;&#x07684;&#x0516d;&#x04e2a;&#x0975e;&#x06d32;&#x056fd;&#x05bb6;&#x04e2d;&#x080fd;&#x0591f;&#x05f71;&#x054cd;&#x0827e;&#x06ecb;&#x075c5;&#x075c5;&#x06bd2;&#x06d4b;&#x08bd5;&#x0548c;&#x06cbb;&#x07597;&#x0670d;&#x052a1;&#x07684;&#x056fd;&#x05bb6;&#x0827e;&#x06ecb;&#x075c5;&#x075c5;&#x06bd2; (HIV) &#x0653f;&#x07b56;&#x03002;</p></sec><sec><title>&#x065b9;&#x06cd5;</title><p>&#x05728;&#x06492;&#x054c8;&#x062c9;&#x06c99;&#x06f20;&#x04ee5;&#x05357;&#x07684;&#x0975e;&#x06d32;&#x056fd;&#x05bb6;&#x04e2d;&#x08fdb;&#x0884c;&#x06709;&#x05173;&#x06210;&#x04eba;&#x06b7b;&#x04ea1;&#x07387;&#x07684;&#x0591a;&#x056fd;&#x07814;&#x07a76;&#x0671f;&#x095f4;,&#x06211;&#x04eec;&#x08bc4;&#x05ba1;&#x04e86;&#x0827e;&#x06ecb;&#x075c5;&#x075c5;&#x06bd2;&#x0653f;&#x07b56;&#x03002;&#x000a0;&#x05f53;&#x065f6;&#x05f00;&#x053d1;&#x04e86;&#x04e00;&#x079cd;&#x0653f;&#x07b56;&#x063d0;&#x053d6;&#x05de5;&#x05177;&#x05e76;&#x05c06;&#x05176;&#x07528;&#x04e8e;&#x08bc4;&#x05ba1;&#x06d25;&#x05df4;&#x05e03;&#x097e6;&#x03001;&#x080af;&#x05c3c;&#x04e9a;&#x03001;&#x09a6c;&#x062c9;&#x07ef4;&#x03001;&#x05357;&#x0975e;&#x03001;&#x05766;&#x06851;&#x05c3c;&#x04e9a;&#x08054;&#x05408;&#x05171;&#x0548c;&#x056fd;&#x04ee5;&#x053ca;&#x04e4c;&#x05e72;&#x08fbe;&#x05728;&#x000a0;2003&#x000a0;&#x05e74;&#x0548c;&#x000a0;2013&#x000a0;&#x05e74;&#x0671f;&#x095f4;&#x051fa;&#x07248;&#x07684;&#x056fd;&#x05bb6;&#x0827e;&#x06ecb;&#x075c5;&#x075c5;&#x06bd2;&#x0653f;&#x07b56;&#x06587;&#x04ef6;&#x0548c;&#x06307;&#x05357;&#x03002;&#x05173;&#x0952e;&#x077e5;&#x060c5;&#x04eba;&#x08bbf;&#x08c08;&#x05e2e;&#x052a9;&#x06211;&#x04eec;&#x05f25;&#x08865;&#x04e86;&#x08c03;&#x067e5;&#x07ed3;&#x0679c;&#x04e2d;&#x07684;&#x04e0d;&#x08db3;&#x04e4b;&#x05904;&#x03002;&#x000a0;&#x06211;&#x04eec;&#x04f9d;&#x0636e;&#x056fd;&#x05bb6;&#x0653f;&#x07b56;&#x0662f;&#x05426;&#x04ee5;&#x0660e;&#x0786e;&#x06216;&#x09690;&#x0542b;&#x07684;&#x065b9;&#x05f0f;&#x09075;&#x05faa;&#x000a0;54&#x000a0;&#x09879;&#x0653f;&#x07b56;&#x06307;&#x06807;&#x06765;&#x05bf9;&#x05176;&#x08fdb;&#x0884c;&#x05206;&#x07c7b;,&#x05e76;&#x04e14;&#x0901a;&#x08fc7;&#x06587;&#x0732e;&#x0548c;&#x04e13;&#x05bb6;&#x08bc4;&#x05ba1;&#x052a0;&#x04ee5;&#x0786e;&#x08ba4;&#x03002;&#x000a0;&#x0540c;&#x065f6;,&#x06211;&#x04eec;&#x08fd8;&#x05bf9;&#x06bd4;&#x04e86;&#x056fd;&#x05bb6;&#x0653f;&#x07b56;&#x0548c;&#x04e16;&#x0754c;&#x0536b;&#x0751f;&#x07ec4;&#x07ec7;&#x000a0;(WHO)&#x000a0;&#x06307;&#x05357;&#x03002;</p></sec><sec><title>&#x07ed3;&#x0679c;</title><p>&#x05404;&#x056fd;&#x07684;&#x0653f;&#x07b56;&#x05dee;&#x05f02;&#x05f88;&#x05927;;&#x06bcf;&#x04e2a;&#x056fd;&#x05bb6;&#x090fd;&#x05728;&#x04e00;&#x04e9b;&#x065b9;&#x09762;&#x08fbe;&#x05230;&#x05148;&#x08fdb;&#x06c34;&#x05e73;,&#x0800c;&#x05728;&#x053e6;&#x04e00;&#x04e9b;&#x065b9;&#x09762;&#x05374;&#x06ca1;&#x06709;&#x08fbe;&#x05230;&#x05148;&#x08fdb;&#x06c34;&#x05e73;&#x03002;&#x000a0;&#x09a6c;&#x062c9;&#x07ef4;&#x05728;&#x063a8;&#x052a8;&#x06297;&#x09006;&#x08f6c;&#x05f55;&#x075c5;&#x06bd2;&#x07597;&#x06cd5;&#x07684;&#x05feb;&#x0901f;&#x0542f;&#x052a8;&#x065b9;&#x09762;&#x05c24;&#x04e3a;&#x05148;&#x08fdb;&#x03002;&#x000a0;&#x07136;&#x0800c;,&#x06ca1;&#x06709;&#x04e00;&#x04e2a;&#x056fd;&#x05bb6;&#x080fd;&#x0591f;&#x07ec8;&#x04fdd;&#x06301;&#x04e00;&#x08d2f;&#x06709;&#x05229;&#x07684;&#x0653f;&#x07b56;&#x073af;&#x05883;,&#x096be;&#x04ee5;&#x06309;&#x09884;&#x0671f;&#x063d0;&#x09ad8;&#x062a4;&#x07406;&#x0666e;&#x053ca;&#x07387;&#x0548c;&#x09884;&#x09632;&#x06d88;&#x08017;&#x03002;&#x000a0;&#x05404;&#x056fd;&#x05728;&#x067d0;&#x04e9b;&#x065b9;&#x09762;&#x08d85;&#x051fa;&#x04e86;&#x04e16;&#x0754c;&#x0536b;&#x0751f;&#x07ec4;&#x07ec7;&#x06307;&#x05357;&#x07684;&#x08303;&#x056f4;,&#x05e76;&#x04e14;&#x0636e;&#x05173;&#x0952e;&#x077e5;&#x060c5;&#x04eba;&#x062a5;&#x0544a;,&#x05b9e;&#x09645;&#x060c5;&#x051b5;&#x05f80;&#x05f80;&#x08d85;&#x08d8a;&#x0653f;&#x07b56;&#x08303;&#x056f4;&#x03002;</p></sec><sec><title>&#x07ed3;&#x08bba;</title><p>&#x08bc4;&#x04f30;&#x0653f;&#x07b56;&#x05dee;&#x05f02;&#x05bf9;&#x0827e;&#x06ecb;&#x075c5;&#x075c5;&#x06bd2;&#x060a3;&#x08005;&#x07684;&#x062a4;&#x07406;&#x0666e;&#x053ca;&#x07387;&#x0548c;&#x0533b;&#x07597;&#x06548;&#x0679c;&#x07684;&#x05f71;&#x054cd;&#x05177;&#x06709;&#x06311;&#x06218;&#x06027;&#x03002;&#x000a0;&#x067d0;&#x04e9b;&#x0653f;&#x07b56;&#x04f1a;&#x06bd4;&#x05176;&#x04ed6;&#x0653f;&#x07b56;&#x04ea7;&#x0751f;&#x066f4;&#x05927;&#x07684;&#x05f71;&#x054cd;,&#x05e76;&#x04e14;&#x05b98;&#x065b9;&#x0653f;&#x07b56;&#x05e76;&#x04e0d;&#x0603b;&#x0662f;&#x080fd;&#x0591f;&#x05f97;&#x05230;&#x0843d;&#x05b9e;&#x03002;&#x000a0;&#x04eca;&#x0540e;&#x07684;&#x07814;&#x07a76;&#x05e94;&#x08bc4;&#x04f30;&#x0653f;&#x07b56;&#x05b9e;&#x065bd;&#x07684;&#x07a0b;&#x05ea6;,&#x05e76;&#x05c06;&#x08fd9;&#x04e9b;&#x08c03;&#x067e5;&#x07ed3;&#x0679c;&#x04e0e;&#x0827e;&#x06ecb;&#x075c5;&#x075c5;&#x06bd2;&#x07684;&#x0533b;&#x07597;&#x06548;&#x0679c;&#x08054;&#x07cfb;&#x08d77;&#x06765;&#x03002;</p></sec></trans-abstract><trans-abstract xml:lang="ru"><title>&#x00420;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;</title><sec><title>&#x00426;&#x00435;&#x0043b;&#x0044c;</title><p>&#x00421;&#x00440;&#x00430;&#x00432;&#x0043d;&#x00438;&#x00442;&#x0044c; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a;&#x00443; &#x00432; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00438; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00438;&#x0043c;&#x0043c;&#x00443;&#x0043d;&#x0043e;&#x00434;&#x00435;&#x00444;&#x00438;&#x00446;&#x00438;&#x00442;&#x00430; &#x00447;&#x00435;&#x0043b;&#x0043e;&#x00432;&#x00435;&#x0043a;&#x00430;&#x000a0;(&#x00412;&#x00418;&#x00427;) &#x00432; &#x00448;&#x00435;&#x00441;&#x00442;&#x00438; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00410;&#x00444;&#x00440;&#x00438;&#x0043a;&#x00438; &#x0043a; &#x0044e;&#x00433;&#x00443; &#x0043e;&#x00442; &#x00421;&#x00430;&#x00445;&#x00430;&#x00440;&#x0044b;. &#x0041e;&#x00446;&#x00435;&#x0043d;&#x00438;&#x00432;&#x00430;&#x00435;&#x00442;&#x00441;&#x0044f; &#x00434;&#x0043e;&#x00441;&#x00442;&#x00443;&#x0043f;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c; &#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00430; &#x0043d;&#x00430; &#x00412;&#x00418;&#x00427; &#x00438; &#x00443;&#x00441;&#x0043b;&#x00443;&#x00433; &#x0043f;&#x0043e; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044e;.</p></sec><sec><title>&#x0041c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0044b;</title><p>&#x0041f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a;&#x00438; &#x00432; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00438; &#x00412;&#x00418;&#x00427; &#x00431;&#x0044b;&#x0043b;&#x00438; &#x00440;&#x00430;&#x00441;&#x00441;&#x0043c;&#x0043e;&#x00442;&#x00440;&#x00435;&#x0043d;&#x0044b; &#x00432; &#x00440;&#x00430;&#x0043c;&#x0043a;&#x00430;&#x00445; &#x0043c;&#x0043d;&#x0043e;&#x00433;&#x0043e;&#x0043d;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00432;&#x00437;&#x00440;&#x0043e;&#x00441;&#x0043b;&#x0043e;&#x00433;&#x0043e; &#x0043d;&#x00430;&#x00441;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00410;&#x00444;&#x00440;&#x00438;&#x0043a;&#x00438; &#x0043a; &#x0044e;&#x00433;&#x00443; &#x0043e;&#x00442; &#x00421;&#x00430;&#x00445;&#x00430;&#x00440;&#x0044b;. &#x00414;&#x0043b;&#x0044f; &#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00430; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a; &#x00431;&#x0044b;&#x0043b; &#x00440;&#x00430;&#x00437;&#x00440;&#x00430;&#x00431;&#x0043e;&#x00442;&#x00430;&#x0043d; &#x00441;&#x0043f;&#x00435;&#x00446;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00438;&#x0043d;&#x00441;&#x00442;&#x00440;&#x00443;&#x0043c;&#x00435;&#x0043d;&#x00442;, &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x00439; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043b;&#x00441;&#x0044f; &#x00434;&#x0043b;&#x0044f; &#x0043f;&#x00440;&#x0043e;&#x00432;&#x00435;&#x00440;&#x0043a;&#x00438; &#x0043e;&#x00444;&#x00438;&#x00446;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x00434;&#x0043e;&#x0043a;&#x00443;&#x0043c;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432; &#x00438; &#x00440;&#x00435;&#x0043a;&#x0043e;&#x0043c;&#x00435;&#x0043d;&#x00434;&#x00430;&#x00446;&#x00438;&#x00439;, &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00441; &#x00433;&#x0043e;&#x00441;&#x00443;&#x00434;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a;&#x0043e;&#x00439; &#x00432; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00438; &#x00412;&#x00418;&#x00427;, &#x0043e;&#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00432; &#x0041a;&#x00435;&#x0043d;&#x00438;&#x00438;, &#x0041c;&#x00430;&#x0043b;&#x00430;&#x00432;&#x00438;, &#x0042e;&#x00436;&#x0043d;&#x0043e;&#x00439; &#x00410;&#x00444;&#x00440;&#x00438;&#x0043a;&#x00435;, &#x00423;&#x00433;&#x00430;&#x0043d;&#x00434;&#x00435;, &#x0041e;&#x00431;&#x0044a;&#x00435;&#x00434;&#x00438;&#x0043d;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x00420;&#x00435;&#x00441;&#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x00435; &#x00422;&#x00430;&#x0043d;&#x00437;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x00438; &#x00417;&#x00438;&#x0043c;&#x00431;&#x00430;&#x00431;&#x00432;&#x00435; &#x00432; &#x0043f;&#x00435;&#x00440;&#x00438;&#x0043e;&#x00434; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; 2003 &#x00438; 2013&#x000a0;&#x00433;&#x00433;. &#x0041d;&#x00435;&#x0044f;&#x00441;&#x0043d;&#x0044b;&#x00435; &#x0043c;&#x0043e;&#x0043c;&#x00435;&#x0043d;&#x00442;&#x0044b; &#x00443;&#x00442;&#x0043e;&#x00447;&#x0043d;&#x0044f;&#x0043b;&#x00438;&#x00441;&#x0044c; &#x00431;&#x0043b;&#x00430;&#x00433;&#x0043e;&#x00434;&#x00430;&#x00440;&#x0044f; &#x0043a;&#x0043b;&#x0044e;&#x00447;&#x00435;&#x00432;&#x0044b;&#x0043c; &#x00438;&#x0043d;&#x00444;&#x0043e;&#x00440;&#x0043c;&#x00430;&#x00442;&#x0043e;&#x00440;&#x00430;&#x0043c;. &#x0041d;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00435; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a;&#x00438; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x0044f;&#x0043b;&#x00438;&#x00441;&#x0044c; &#x0043f;&#x0043e; &#x0043a;&#x00430;&#x00442;&#x00435;&#x00433;&#x0043e;&#x00440;&#x00438;&#x0044f;&#x0043c; &#x00432; &#x00437;&#x00430;&#x00432;&#x00438;&#x00441;&#x00438;&#x0043c;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043e;&#x00442; &#x00442;&#x0043e;&#x00433;&#x0043e;, &#x0043f;&#x00440;&#x00438;&#x00434;&#x00435;&#x00440;&#x00436;&#x00438;&#x00432;&#x00430;&#x0043b;&#x00438;&#x00441;&#x0044c; &#x0043b;&#x00438; &#x0043e;&#x0043d;&#x00438; &#x0044f;&#x00432;&#x0043d;&#x0044b;&#x0043c; &#x00438;&#x0043b;&#x00438; &#x0043a;&#x0043e;&#x00441;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x0043c; &#x0043e;&#x00431;&#x00440;&#x00430;&#x00437;&#x0043e;&#x0043c; 54&#x000a0;&#x0043f;&#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x00442;&#x00435;&#x0043b;&#x00435;&#x00439;, &#x00432;&#x0044b;&#x0044f;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00432; &#x00445;&#x0043e;&#x00434;&#x00435; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043a;&#x00438; &#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x00430;&#x00446;&#x00438;&#x00439; &#x00438; &#x0043e;&#x00442;&#x00447;&#x00435;&#x00442;&#x0043e;&#x00432; &#x00441;&#x0043f;&#x00435;&#x00446;&#x00438;&#x00430;&#x0043b;&#x00438;&#x00441;&#x00442;&#x0043e;&#x00432;. &#x00411;&#x0044b;&#x0043b;&#x0043e; &#x00442;&#x00430;&#x0043a;&#x00436;&#x00435; &#x0043f;&#x00440;&#x0043e;&#x00432;&#x00435;&#x00434;&#x00435;&#x0043d;&#x0043e; &#x00441;&#x00440;&#x00430;&#x00432;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043d;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a; &#x00441; &#x00440;&#x00435;&#x0043a;&#x0043e;&#x0043c;&#x00435;&#x0043d;&#x00434;&#x00430;&#x00446;&#x00438;&#x0044f;&#x0043c;&#x00438; &#x00412;&#x00441;&#x00435;&#x0043c;&#x00438;&#x00440;&#x0043d;&#x0043e;&#x00439; &#x0043e;&#x00440;&#x00433;&#x00430;&#x0043d;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00438; &#x00437;&#x00434;&#x00440;&#x00430;&#x00432;&#x0043e;&#x0043e;&#x00445;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f;&#x000a0;(&#x00412;&#x0041e;&#x00417;).</p></sec><sec><title>&#x00420;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b;</title><p>&#x0041f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a;&#x00438; &#x00432; &#x00440;&#x00430;&#x00437;&#x0043d;&#x0044b;&#x00445; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x0043e;&#x00442;&#x0043b;&#x00438;&#x00447;&#x00430;&#x0043b;&#x00438;&#x00441;&#x0044c; &#x00434;&#x00440;&#x00443;&#x00433; &#x0043e;&#x00442; &#x00434;&#x00440;&#x00443;&#x00433;&#x00430;; &#x00432; &#x0043a;&#x00430;&#x00436;&#x00434;&#x0043e;&#x00439; &#x00438;&#x00437; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d; &#x0043e;&#x00442;&#x0043c;&#x00435;&#x00447;&#x00430;&#x0043b;&#x00441;&#x0044f; &#x0043f;&#x00440;&#x0043e;&#x00433;&#x00440;&#x00435;&#x00441;&#x00441; &#x00432; &#x0043e;&#x00434;&#x0043d;&#x00438;&#x00445; &#x0043e;&#x00431;&#x0043b;&#x00430;&#x00441;&#x00442;&#x0044f;&#x00445; &#x00438; &#x0043e;&#x00442;&#x00441;&#x00442;&#x00430;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00435; &#x00432; &#x00434;&#x00440;&#x00443;&#x00433;&#x00438;&#x00445;. &#x00412; &#x00447;&#x00430;&#x00441;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438;, &#x0041c;&#x00430;&#x0043b;&#x00430;&#x00432;&#x00438; &#x00437;&#x0043d;&#x00430;&#x00447;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e; &#x00432;&#x0044b;&#x00434;&#x00435;&#x0043b;&#x0044f;&#x0043b;&#x00430;&#x00441;&#x0044c; &#x0043f;&#x00440;&#x0043e;&#x00434;&#x00432;&#x00438;&#x00436;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00440;&#x00430;&#x0043d;&#x0043d;&#x00435;&#x00433;&#x0043e; &#x0043d;&#x00430;&#x00447;&#x00430;&#x0043b;&#x00430; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00440;&#x00435;&#x00442;&#x00440;&#x0043e;&#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x0043d;&#x0043e;&#x00439; &#x00442;&#x00435;&#x00440;&#x00430;&#x0043f;&#x00438;&#x00438;. &#x00422;&#x00435;&#x0043c; &#x0043d;&#x00435; &#x0043c;&#x00435;&#x0043d;&#x00435;&#x00435; &#x0043d;&#x00438; &#x00432; &#x0043e;&#x00434;&#x0043d;&#x0043e;&#x00439; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00435; &#x0043d;&#x00435; &#x00431;&#x0044b;&#x0043b;&#x00430; &#x00440;&#x00435;&#x00430;&#x0043b;&#x00438;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00430; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0043d;&#x00430;&#x0044f; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a;&#x00430;, &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x00430;&#x0044f; &#x0043e;&#x00431;&#x0043b;&#x00435;&#x00433;&#x00447;&#x00430;&#x0043b;&#x00430; &#x00431;&#x0044b; &#x00434;&#x0043e;&#x00441;&#x00442;&#x00443;&#x0043f; &#x0043a; &#x0043c;&#x00435;&#x00434;&#x00438;&#x00446;&#x00438;&#x0043d;&#x00441;&#x0043a;&#x0043e;&#x00439; &#x0043f;&#x0043e;&#x0043c;&#x0043e;&#x00449;&#x00438; &#x00438; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x0044f;&#x00442;&#x00441;&#x00442;&#x00432;&#x0043e;&#x00432;&#x00430;&#x0043b;&#x00430; &#x00431;&#x0044b; &#x0043e;&#x00442;&#x00442;&#x0043e;&#x0043a;&#x00443; &#x0043f;&#x00435;&#x00440;&#x00441;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x00430;. &#x00412; &#x0043d;&#x00435;&#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x00445; &#x0043e;&#x00431;&#x0043b;&#x00430;&#x00441;&#x00442;&#x0044f;&#x00445; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x0044b; &#x0043f;&#x0043e;&#x00448;&#x0043b;&#x00438; &#x00434;&#x00430;&#x0043b;&#x0044c;&#x00448;&#x00435; &#x00440;&#x00435;&#x0043a;&#x0043e;&#x0043c;&#x00435;&#x0043d;&#x00434;&#x00430;&#x00446;&#x00438;&#x00439; &#x00412;&#x0041e;&#x00417; &#x00438; &#x0043e;&#x00441;&#x0043d;&#x0043e;&#x00432;&#x0043d;&#x0044b;&#x00435; &#x00438;&#x0043d;&#x00444;&#x0043e;&#x00440;&#x0043c;&#x00430;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x00441;&#x0043e;&#x0043e;&#x00431;&#x00449;&#x00438;&#x0043b;&#x00438;, &#x00447;&#x00442;&#x0043e; &#x0043f;&#x00440;&#x00430;&#x0043a;&#x00442;&#x00438;&#x0043a;&#x00430; &#x00447;&#x00430;&#x00441;&#x00442;&#x0043e; &#x0043e;&#x0043f;&#x00435;&#x00440;&#x00435;&#x00436;&#x00430;&#x0043b;&#x00430; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a;&#x00443;.</p></sec><sec><title>&#x00412;&#x0044b;&#x00432;&#x0043e;&#x00434;</title><p>&#x0041e;&#x00446;&#x00435;&#x0043d;&#x00438;&#x00442;&#x0044c;, &#x0043d;&#x00430;&#x00441;&#x0043a;&#x0043e;&#x0043b;&#x0044c;&#x0043a;&#x0043e; &#x0043e;&#x00442;&#x0043b;&#x00438;&#x00447;&#x00438;&#x0044f; &#x00432; &#x00433;&#x0043e;&#x00441;&#x00443;&#x00434;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a;&#x00435; &#x00432;&#x0043b;&#x00438;&#x0044f;&#x0044e;&#x00442; &#x0043d;&#x00430; &#x00434;&#x0043e;&#x00441;&#x00442;&#x00443;&#x0043f; &#x0043a; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x00438; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b; &#x0043c;&#x00435;&#x00440;&#x0043e;&#x0043f;&#x00440;&#x00438;&#x0044f;&#x00442;&#x00438;&#x00439; &#x0043f;&#x0043e; &#x0043e;&#x00445;&#x00440;&#x00430;&#x0043d;&#x00435; &#x00437;&#x00434;&#x0043e;&#x00440;&#x0043e;&#x00432;&#x0044c;&#x0044f; &#x00434;&#x0043b;&#x0044f; &#x0043b;&#x00438;&#x00446;, &#x00436;&#x00438;&#x00432;&#x00443;&#x00449;&#x00438;&#x00445; &#x00441; &#x00412;&#x00418;&#x00427;, &#x00434;&#x0043e;&#x00432;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x0043e; &#x00441;&#x0043b;&#x0043e;&#x00436;&#x0043d;&#x0043e;. &#x0041d;&#x00435;&#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x00435; &#x00438;&#x00437; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a; &#x00438;&#x0043c;&#x00435;&#x0044e;&#x00442; &#x00441;&#x00440;&#x00430;&#x00432;&#x0043d;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e; &#x00431;&#x0043e;&#x0043b;&#x0044c;&#x00448;&#x00438;&#x00439; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;, &#x00438; &#x0043e;&#x00444;&#x00438;&#x00446;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x00430;&#x0044f; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a;&#x00430; &#x0043d;&#x00435; &#x00432;&#x00441;&#x00435;&#x00433;&#x00434;&#x00430; &#x00432;&#x0044b;&#x0043f;&#x0043e;&#x0043b;&#x0043d;&#x0044f;&#x00435;&#x00442;&#x00441;&#x0044f;. &#x00412; &#x00431;&#x00443;&#x00434;&#x00443;&#x00449;&#x00438;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x00445; &#x0043d;&#x00435;&#x0043e;&#x00431;&#x00445;&#x0043e;&#x00434;&#x00438;&#x0043c;&#x0043e; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x00438;&#x00442;&#x0044c; &#x00441;&#x00442;&#x00435;&#x0043f;&#x00435;&#x0043d;&#x0044c; &#x00432;&#x0044b;&#x0043f;&#x0043e;&#x0043b;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x00442;&#x00438;&#x0043a; &#x00438; &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x00442;&#x0044c; &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00441; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x00430;&#x0043c;&#x00438; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00412;&#x00418;&#x00427;.</p></sec></trans-abstract></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>By the end of 2012, more than 7.5 million of the estimated 23.5 million people living with human immunodeficiency virus (HIV) in Africa were receiving treatment, compared to only 50&#x02009;000 people a decade before.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> The scale-up of treatment services in such a short period of time has been remarkable. Recent evidence suggests that HIV-attributable mortality has declined by more than 50% since antiretroviral therapy (ART) became available.<xref rid="R2" ref-type="bibr"><sup>2</sup></xref><sup>&#x02013;</sup><xref rid="R8" ref-type="bibr"><sup>8</sup></xref></p><p>Nonetheless, considerable concerns remain regarding high attrition rates throughout the continuum of care from HIV diagnosis, pre-ART care, timely initiation of ART and long-term retention in treatment.<xref rid="R9" ref-type="bibr"><sup>9</sup></xref> Various studies have observed substantial drop-out of people living with HIV across this care cascade. A recent pooled analysis of 37 studies in sub-Saharan Africa indicates that among those knowing their status, only 57% completed ART eligibility assessment, 66% of those eligible initiated ART and 65% of those initiating treatment were retained on ART.<xref rid="R10" ref-type="bibr"><sup>10</sup></xref></p><p>The network for analysing longitudinal population-based data on HIV in Africa (ALPHA) is investigating the extent of declines in HIV-related adult mortality attributable to treatment and the distribution of deaths at each stage of the diagnosis-to-treatment cascade.<xref rid="R11" ref-type="bibr"><sup>11</sup></xref><sup>&#x02013;</sup><xref rid="R14" ref-type="bibr"><sup>14</sup></xref> The network collects community-based data from 10 health and demographic surveillance sites in six countries with generalized epidemics &#x02013; Kenya, Malawi, South Africa, Uganda, the United Republic of Tanzania and Zimbabwe. <xref ref-type="table" rid="T1">Table&#x000a0;1</xref> identifies the ALPHA network sites and provides contextual information on the epidemic and treatment programme in each country.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Characteristics of the HIV epidemic in the six African countries<xref rid="R9" ref-type="bibr"><sup>9</sup></xref><sup>, </sup><xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>-</sup><xref rid="R24" ref-type="bibr"><sup>24</sup></xref></title></caption><table frame="hsides" rules="groups"><col width="120" span="1"/><col width="73" span="1"/><col width="70" span="1"/><col width="105" span="1"/><col width="70" span="1"/><col width="79" span="1"/><col width="72" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Characteristic</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Kenya</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Malawi</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">South Africa</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Uganda</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">United Republic of Tanzania</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Zimbabwe</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Demographic surveillance site(s)</td><td valign="top" align="center" rowspan="1" colspan="1">Nairobi and Kisumu</td><td valign="top" align="center" rowspan="1" colspan="1">Karonga</td><td valign="top" align="center" rowspan="1" colspan="1">Agincourt and UmKhanyakude</td><td valign="top" align="center" rowspan="1" colspan="1">Masaka and Rakai</td><td valign="top" align="center" rowspan="1" colspan="1">Ifakara and Kisesa</td><td valign="top" align="center" rowspan="1" colspan="1">Manicaland</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Adult HIV prevalence in 2013<xref rid="R15" ref-type="bibr"><sup>15</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">6.0</td><td valign="top" align="center" rowspan="1" colspan="1">10.3</td><td valign="top" align="center" rowspan="1" colspan="1">19.1</td><td valign="top" align="center" rowspan="1" colspan="1">7.4</td><td valign="top" align="center" rowspan="1" colspan="1">5.0</td><td valign="top" align="center" rowspan="1" colspan="1">15.0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Year of public sector ART introduction</td><td valign="top" align="center" rowspan="1" colspan="1">2006</td><td valign="top" align="center" rowspan="1" colspan="1">2004</td><td valign="top" align="center" rowspan="1" colspan="1">2003/2004</td><td valign="top" align="center" rowspan="1" colspan="1">2004</td><td valign="top" align="center" rowspan="1" colspan="1">2003/2004</td><td valign="top" align="center" rowspan="1" colspan="1">2004</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Adult ART coverage in 2013<sup>a</sup> % (range)<xref rid="R15" ref-type="bibr"><sup>15</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">42 (39&#x02013;46)</td><td valign="top" align="center" rowspan="1" colspan="1">51 (48&#x02013;53)</td><td valign="top" align="center" rowspan="1" colspan="1">42 (40&#x02013;43)</td><td valign="top" align="center" rowspan="1" colspan="1">40 (38&#x02013;43)</td><td valign="top" align="center" rowspan="1" colspan="1">41 (38&#x02013;44)</td><td valign="top" align="center" rowspan="1" colspan="1">51 (49&#x02013;53)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PMTCT coverage in 2013<sup>b</sup> % (range)<xref rid="R15" ref-type="bibr"><sup>15</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">63 (55&#x02013;72)</td><td valign="top" align="center" rowspan="1" colspan="1">79 (71&#x02013;88)</td><td valign="top" align="center" rowspan="1" colspan="1">90 (83&#x02013;&#x02009;95)</td><td valign="top" align="center" rowspan="1" colspan="1">75 (68&#x02013;85)</td><td valign="top" align="center" rowspan="1" colspan="1">73 (65&#x02013;83)</td><td valign="top" align="center" rowspan="1" colspan="1">78 (70&#x02013;87)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Adults knowing their HIV status<sup>c</sup> %</td><td valign="top" align="center" rowspan="1" colspan="1">36&#x02013;56<xref rid="R16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="R17" ref-type="bibr"><sup>17</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">28<xref rid="R18" ref-type="bibr"><sup>18</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">36&#x02013;55<xref rid="R19" ref-type="bibr"><sup>19</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">56<xref rid="R20" ref-type="bibr"><sup>20</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">54.5<xref rid="R21" ref-type="bibr"><sup>21</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">46.5<xref rid="R22" ref-type="bibr"><sup>22</sup></xref></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Pregnant women knowing their HIV status in 2013<xref rid="R23" ref-type="bibr"><sup>23</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">88</td><td valign="top" align="center" rowspan="1" colspan="1">76</td><td valign="top" align="center" rowspan="1" colspan="1">93</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;&#x02009;95</td><td valign="top" align="center" rowspan="1" colspan="1">70</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;&#x02009;95</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Donor funding as a proportion of total HIV/AIDS budget in 2013<xref rid="R9" ref-type="bibr"><sup>9</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">75&#x02013;100</td><td valign="top" align="center" rowspan="1" colspan="1">75&#x02013;100</td><td valign="top" align="center" rowspan="1" colspan="1">0&#x02013;24</td><td valign="top" align="center" rowspan="1" colspan="1">75&#x02013;100</td><td valign="top" align="center" rowspan="1" colspan="1">50&#x02013;74</td><td valign="top" align="center" rowspan="1" colspan="1">75&#x02013;100</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Doctors per 100&#x02009;000 people<xref rid="R24" ref-type="bibr"><sup>24</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.2</td><td valign="top" align="center" rowspan="1" colspan="1">7.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.1</td><td valign="top" align="center" rowspan="1" colspan="1">1.2</td><td valign="top" align="center" rowspan="1" colspan="1">0.6</td></tr></tbody></table><table-wrap-foot><p>AIDS: acquired immunodeficiency syndrome; ART: antiretroviral therapy; HIV: human immunodeficiency virus; PMTCT: prevention of mother-to-child transmission.</p><p><sup>a</sup> Defined as the percentage of adults (15 years and older) living with HIV and receiving ART.</p><p><sup>b</sup> Defined as the estimated percentage of pregnant women living with HIV who received antiretroviral medicines for PMTCT.</p><p><sup>c</sup> Defined as testing at least once in the last 12 months and receiving results. Note that dates of studies vary.</p></table-wrap-foot></table-wrap><p>To interpret site- and country-specific differences in mortality rates across the diagnosis-to-treatment cascade, we analysed national HIV policies. It is helpful for the agencies that define programme priorities and analyse differences in outcomes to understand the incentives and barriers to accessing &#x02013; and remaining on &#x02013; ART in different contexts. Our analysis focuses on the policy response to the HIV epidemic. We have not investigated the sociocultural barriers within communities that influence access to services in different sites.</p></sec><sec sec-type="methods"><title>Methods</title><p>A conceptual framework was developed, identifying key HIV policy and programmatic factors that may influence HIV-related adult mortality (<xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>). These factors were derived from a review of the literature (including a recent systematic review on health sector interventions to ensure a continuum of care),<xref rid="R10" ref-type="bibr"><sup>10</sup></xref> an initial review of World Health Organization (WHO) guidelines and expert review of indicators by 28 HIV researchers and clinicians. Through the literature review and preliminary analysis of ALPHA network mortality data, we identified three attrition points to inform the structure of our policy review: (i)&#x000a0;access to HIV testing and counselling; (ii)&#x000a0;access to HIV care and treatment (including assessment of eligibility for treatment initiation and initiation itself); and (iii)&#x000a0;retention on ART. Across these three attrition points (diagnosis, HIV care and retention), relevant factors fell into the following five areas: (i)&#x000a0;service access and coverage; (ii)&#x000a0;quality of care; (iii)&#x000a0;coordination of care and patient tracking; (iv)&#x000a0;medical management; and (v)&#x000a0;support to people living with HIV.</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Conceptual framework of HIV policy and service factors influencing HIV-related adult mortality</p></caption><p>ART: antiretroviral therapy; HIV: human immunodeficiency virus. PLHIV: people living with HIV.</p><p>Note: Factors in italics are only measurable and comparable through facility-based research and are not included in this review.</p><graphic xlink:href="BLT.14.147215-F1"/></fig><p>A policy extraction tool was developed to facilitate the indicator review (available from the author). Documents were searched online through ministry of health and national HIV organization websites and/or retrieved in person from official offices and libraries, using the following inclusion criteria: (i)&#x000a0;nationally relevant (not clinic- or district-specific); (ii)&#x000a0;containing programmatic or clinical guidance on one of the three key adult HIV services: HIV testing and counselling, prevention of mother-to-child transmission (PMTCT) or HIV care and treatment; (iii)&#x000a0;published between January 2003 and June 2013. Documents likely to fit these three criteria were considered, including policy statements, clinical guidelines, training manuals, strategies, indicator guides and parliamentary acts. Guideline documents produced by WHO relevant to criteria (ii) and (iii) were also included.</p><p>The policy extraction tool was used to collect information on policy content, source, year and policy changes over time. Country teams completed gaps in data collection using unstructured informal interviews with key informants. Informants were either regional or national policy-makers, researchers or clinicians involved in policy development.</p><p>We summarized key policies judged most likely to affect access to HIV testing, access to HIV care and treatment and retention on ART. For each indicator, each country&#x02019;s policy was categorized into one of the following: (i)&#x000a0;has explicit policy; (ii)&#x000a0;has implicit policy or policy has caveats or exceptions; (iii)&#x000a0;is unclear whether policy exists or policy conflicts with other policies; or (iv)&#x000a0;does not have policy. We also assessed whether the policy was consistent with WHO guidance or a country standard that went beyond such guidance.</p></sec><sec sec-type="results"><title>Results</title><p>A total of 120 policy documents with guidance relevant to the indicators were identified and reviewed; references are available from the author.</p><sec><title>Access to testing</title><p><xref ref-type="fig" rid="F2">Fig.&#x000a0;2</xref> summarizes policies influencing access to HIV testing. Policies in the six countries were generally consistent and explicitly or partially adhered to the policy indicators, including provision of free testing services and provider-initiated testing and counselling. Malawi was the only country with no policy targeting testing among high-risk groups; while Uganda and the United Republic of Tanzania did not define the high-risk groups. Only South Africa and Uganda had explicit policies enabling minors to access testing without parental consent.</p><fig id="F2" fig-type="figure" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>WHO guidance and policies in six African countries influencing access to HIV testing, 2003 to mid-2013 <xref rid="R25" ref-type="bibr"><sup>25</sup></xref><sup>&#x02013;</sup><xref rid="R56" ref-type="bibr"><sup>56</sup></xref></p></caption><p>ANC: antenatal care; HIV: human immunodeficiency virus; PITC: provider-initiated testing and counselling for HIV; WHO: World Health Organization.</p><p><sup>a</sup> Information from key informant interview.</p><graphic xlink:href="BLT.14.147215-F2"/></fig><p>Indicators related to quality of care were more variable. Anonymous HIV testing was guaranteed only in South Africa and Zimbabwe, whereas in Kenya, Uganda and the United Republic of Tanzania names could be recorded in registers to facilitate patient management. Various WHO documents emphasized confidentiality and protection from discrimination, but did not offer explicit guidance on maintaining anonymity. Only Kenya and the United Republic of Tanzania had policies limiting the number of testing sessions that counsellors can perform per day. While all countries stipulated the need for periodic refresher training for counsellors and quality control checks at sites, they varied in stated frequency, with the United Republic of Tanzania and Zimbabwe most explicit about how often retraining is required.</p><p>Policies influencing coordination of care and patient tracking were more ambiguous in the United Republic of Tanzania where there was no clear policy on repeat testing intervals for negatives or on repeat testing during pregnancy, labour or after delivery. Malawi was also ambiguous in this area, with repeat testing for negatives advised every 6&#x02013;12 months for high-risk individuals and no explicit policy on repeat testing during pregnancy.</p><p>Regarding patient support, Malawi, South Africa and Uganda also stipulated that pretest HIV counselling be conducted either individually or in groups; others recommended at least one individual session. While all countries promoted couple counselling, this was not explicit in WHO guidance.</p></sec><sec><title>Access to care and treatment</title><p><xref ref-type="fig" rid="F3">Fig.&#x000a0;3</xref> summarizes policies influencing access to care and treatment services, which varied more across countries. Free public sector access to PMTCT and ART was guaranteed everywhere, either explicitly in HIV policies or national health policies or implied in the national constitution, although WHO documents only implied free public sector access through promotion of universal access to HIV services. All countries promoted PMTCT availability within antenatal care and all allowed task-shifting of ART initiation to clinical officers, medical assistants or nurses (albeit with important variations in year of policy formulation, with Kenya, Malawi and the United Republic of Tanzania allowing task shifting as early as 2004/2005). Only Malawi and Uganda had explicit policies stating that all sites providing ART should also be able to initiate ART.</p><fig id="F3" fig-type="figure" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>WHO guidance and policies in six African countries influencing access to HIV care and treatment, 2003 to mid-2013 <xref rid="R26" ref-type="bibr"><sup>26</sup></xref><sup>,</sup><xref rid="R29" ref-type="bibr"><sup>29</sup></xref><sup>,</sup><xref rid="R31" ref-type="bibr"><sup>31</sup></xref><sup>,</sup><xref rid="R34" ref-type="bibr"><sup>34</sup></xref><sup>,</sup><xref rid="R42" ref-type="bibr"><sup>42</sup></xref><sup>,</sup><xref rid="R45" ref-type="bibr"><sup>45</sup></xref><sup>,</sup><xref rid="R52" ref-type="bibr"><sup>52</sup></xref><sup>&#x02013;</sup><xref rid="R55" ref-type="bibr"><sup>55</sup></xref><sup>,</sup><xref rid="R57" ref-type="bibr"><sup>57</sup></xref><sup>&#x02013;</sup><xref rid="R84" ref-type="bibr"><sup>84</sup></xref></p></caption><p>ANC: antenatal care; ART: antiretroviral therapy; ARV: antiretroviral; CD4: cluster of differentiation 4; FBC: full blood count; HIV: human immunodeficiency virus; LFTS/RFTS: liver function/renal function tests; MCH: maternal and child health; MDR/XDR: multi-drug resistant/extensively-drug resistant; PMTCT: prevention of mother-to-child transmission; WHO: World Health Organization.</p><p><sup>a</sup> Information from key informant interview.</p><graphic xlink:href="BLT.14.147215-F3"/></fig><p>All countries had explicit policies on the need for CD4+ T-lymphocyte (CD4+ cells) testing at least every six months in the pre-ART phase and all recorded pre-ART visits in patient registers or forms. Only Kenya, Uganda and the United Republic of Tanzania had explicit policies on patient follow-up to ensure registration at treatment sites. All countries except Zimbabwe stipulated the need for PMTCT-ART referral, but only South Africa and the United Republic of Tanzania indicated when this referral should occur (six&#x000a0;weeks after birth). Service integration between maternal and child health and ART was encouraged explicitly in Kenya, Malawi, Uganda and Zimbabwe.</p><p>Most countries adhered to WHO&#x02019;s 2010 Option&#x000a0;B regimen for PMTCT (provision of triple drug therapy to the mother during pregnancy until delivery or cessation of breastfeeding), except the United Republic of Tanzania which still adhered to WHO&#x02019;s Option&#x000a0;A regimen at the time of the review (single dose drug therapy with zidovudine [AZT] during pregnancy, triple therapy at onset of labour using nevirapine, AZT and lamivudine [3TC], followed by dual drug therapy for seven days postpartum with AZT and 3TC). Malawi was the only country to have explicitly adopted WHO&#x02019;s Option&#x000a0;B+ regimen (initiation of life-long triple ART therapy during pregnancy) for all women in 2011, which was earlier than WHO guidance. Roll-out of Option&#x000a0;B+ in Kenya and Uganda was dependent on the capacity of the health facility to initiate triple therapy.</p><p>Most countries had explicit policies allowing all people co-infected with HIV and tuberculosis to initiate ART, but differed markedly in their year of uptake of this policy, ranging from 2004 in Malawi, to 2013 in South Africa. Country guidance varied on tuberculosis and HIV treatment initiation: Malawi and Uganda stated that co-infected patients must initiate ART on the same day or within two&#x000a0;weeks of starting tuberculosis treatment (going beyond WHO guidance of within eight&#x000a0;weeks); while Kenya and the United Republic of Tanzania stated that treatment should preferably be initiated within two&#x000a0;weeks. While all countries shared the standard ART initiation criteria, only Kenya and Malawi stipulated explicitly that ART should be initiated within seven&#x000a0;days of being found eligible for treatment. Malawi and South Africa also had more liberal policies allowing ART initiation with minimum requirements for tests and counselling. Malawi has not required laboratory tests for initiation since the beginning of the treatment programme (2004). South Africa brought in this change in 2013 and stated that adherence counselling should not be compulsory before initiation.</p></sec><sec><title>Retention on ART</title><p><xref ref-type="fig" rid="F4">Fig.&#x000a0;4</xref> summarizes policies influencing retention on ART. Stipulating that ART clinics include a doctor or clinical officer could be a barrier to access in resource-constrained contexts. This requirement is still applied in Kenya, Malawi, the United Republic of Tanzania and Zimbabwe (even though task-shifting for initiation occurred). Quality indicators also varied, with staff retraining and quality control intervals varying or not made explicit; for example no quality control was required after initial accreditation in South Africa, versus quarterly checks in Malawi, Uganda and the United Republic of Tanzania.</p><fig id="F4" fig-type="figure" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>WHO guidance and policies in six African countries influencing retention on ART, 2003&#x02013;mid-2013 <xref rid="R36" ref-type="bibr"><sup>36</sup></xref><sup>,</sup><xref rid="R46" ref-type="bibr"><sup>46</sup></xref><sup>,</sup><xref rid="R53" ref-type="bibr"><sup>53</sup></xref><sup>,</sup><xref rid="R56" ref-type="bibr"><sup>56</sup></xref><sup>,</sup><xref rid="R58" ref-type="bibr"><sup>58</sup></xref><sup>,</sup><xref rid="R60" ref-type="bibr"><sup>60</sup></xref><sup>,</sup><xref rid="R62" ref-type="bibr"><sup>62</sup></xref><sup>,</sup><xref rid="R67" ref-type="bibr"><sup>67</sup></xref><sup>,</sup><xref rid="R69" ref-type="bibr"><sup>69</sup></xref><sup>,</sup><xref rid="R70" ref-type="bibr"><sup>70</sup></xref><sup>,</sup><xref rid="R73" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="R76" ref-type="bibr"><sup>76</sup></xref><sup>,</sup><xref rid="R81" ref-type="bibr"><sup>81</sup></xref><sup>&#x02013;</sup><xref rid="R96" ref-type="bibr"><sup>96</sup></xref></p></caption><p>3TC: lamivudine; ART: antiretroviral therapy; AZT: zidovudine; CD4: cluster of differentiation 4; d4T: stavudine; EFV: efavirenz; HIV: human immunodeficiency virus; IPT: isoniazid preventive therapy; NVP: nevirapine; WHO: World Health Organization.</p><p><sup>a</sup> Information from key informant interview.</p><graphic xlink:href="BLT.14.147215-F4"/></fig><p>There were also important differences in coordination of care and patient tracking. Since the beginning of the treatment programme, Malawi did not promote routine CD4 monitoring, unlike all other countries where yearly or six-monthly monitoring was standard. While most countries advised that stable patients receive a three-month supply of drugs, two months of supplies were stipulated in the United Republic of Tanzania and one month in South Africa. All countries promoted regular pill counts, but only South Africa and Zimbabwe had explicit policies on home visits following signs of poor adherence &#x02013; others recommended home visits or telephone contact following missed appointments. Only Kenya explicitly recommended daily register reviews to identify missed appointments. Definitions of missed appointments and loss to follow-up varied: Zimbabwe was most reactive with a missed appointment defined as a one-week delay, followed by Malawi where a two-week absence triggered action. Most countries defined loss to follow-up or defaulting as no attendance within 90 days of the last visit, but the number of days was not defined in Malawi and was unclear in South Africa. Malawi, Uganda and the United Republic of Tanzania also allowed drug collection by designees (treatment partners/guardians).</p><p>Support to those on ART varied. All countries explicitly or implicitly recommended individual adherence counselling, but Malawi and Uganda did not stipulate referral to peer-support. Kenya and Uganda provided nutritional support to ART patients; Malawi stopped this in adults due to lack of evidence. Only South Africa, the United Republic of Tanzania and Zimbabwe routinely referred all ART patients to home-based care programmes.</p><p>All sites recommended routine screening for tuberculosis, but Zimbabwe did not routinely provide isoniazid preventive therapy for tuberculosis prevention. All countries except Zimbabwe recommended at least four first-line ART regimen choices to patients, but not all complied with WHO&#x02019;s 2010 recommended first line standard therapy (tenofovir, 3TC and nevirapine/efavirenz). Zimbabwe was the first to introduce WHO&#x02019;s recommended regimen in 2010. All countries except Malawi had clear criteria for switching to efavirenz-based regimens for patients who develop tuberculosis.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Here we demonstrate wide variation in national HIV policies influencing service access and attrition through the diagnosis-to-treatment cascade across six countries with generalized HIV epidemics. Given that African countries usually adopt guidance from WHO, such a degree of policy variation is surprising.</p><p>Several indicators were consistent across all countries, but for many indicators, countries were progressive in selected areas and no country stood out as having a consistently enabling policy context that would have a decisive impact on service access and attrition. In Malawi, for example, policies designed to facilitate access to care (such as no requirements for routine CD4 testing, early adoption of the Option&#x000a0;B+ PMTCT regimen, rapid ART initiation for those eligible), contrasted with certain policy gaps (such as targeted testing for high-risk groups, repeat testing during labour/after delivery, referral to peer support or home-based care for patients on ART). South Africa is another case where policies aiming to enhance access in some areas contrasted with policy gaps in others. South Africa had policies on anonymous HIV testing, home visits following signs of poor adherence and few barriers to starting ART (no required laboratory tests, adherence counselling, or physician presence in ART clinics), but lacked policies on quality control for ART, provision of three-monthly ART supplies, guidance on missed appointments or loss to follow-up and compliance with WHO first-line regimen standards. In the United Republic of Tanzania, an enabling policy environment for retention of patients in care and treatment contrasted with the slow adoption of WHO Option&#x000a0;B+ and ART regimens containing tenofovir (both subsequently adopted in September 2013), as well as weaknesses in repeat testing intervals.</p><p>There were also important differences in the timing of policy implementation in some indicators. Malawi adopted Option&#x000a0;B+ in 2011 (before WHO guidance) and has not required laboratory tests for ART initiation since 2004 (versus South Africa, which made this change in 2013). Policies to trace missed appointments with home visits or phone contacts vary in dates of implementation from 2004&#x02013;2005 in Malawi and the United Republic of Tanzania, to 2011 in Kenya. While countries often lagged behind WHO in national policy adoption, in some instances countries went beyond WHO standards; notable examples included policies related to pre-ART-CD4 monitoring intervals, rapid initiation of ART, task-shifting for ART initiation, drug resupply intervals, pill count recommendations, drug collection by designees, referral to peer support and home-based care. The fact that WHO had no explicit guidance on such topics may contribute to the differences in adoption of policies across countries.</p><p>Policies are likely to differ in their potential impact on service access and attrition. We are unable to judge, therefore, how policy differences are likely to influence mortality. There seems to be little correlation between policy profile and service coverage (<xref ref-type="table" rid="T1">Table&#x000a0;1</xref>). Our analysis did not attempt to weight policies &#x02013; as this is likely to be highly subjective. One might expect that policies on patient coordination and tracking (e.g. pre-ART monitoring, timely initiation of ART and adherence monitoring) have greater impact than policies on quality of care (e.g. staff training or quality audits). The relative emphasis on different policies also varied; some indicators were only mentioned once in one document, while others were core tenets of HIV service delivery and repeatedly mentioned.</p><p>We attempted to frame all policies as designed to increase service access and reduce attrition, but the direction of effect was not always clear-cut. For example, anonymous testing may promote access to diagnosis by reducing stigma, but may hamper linkage to care. Group pretest counselling may facilitate test access but have quality implications. Requiring people co-infected with HIV and tuberculosis to stabilize on tuberculosis treatment before initiating ART may be beneficial only for patients with very low CD4 counts.<xref rid="R97" ref-type="bibr"><sup>97</sup></xref> Allowing certain sites to provide ART refills may also be advantageous, allowing patients to access drugs nearer home. Fast-tracking patients into care (with rapid ART initiation and no requirements for laboratory tests or adherence counselling) may increase immediate uptake of services, but could undermine long-term adherence if patients are inadequately prepared for treatment. Not insisting on routine CD4 monitoring of ART patients in Malawi forms an important aspect of the public health approach to scaling up access, but may have negative consequences for timely identification of treatment failure.</p><p>Our review has some limitations. First, establishing the precise date of policy enactment was challenging. Publication dates represent formal enactment, but key informants reported instances in which policies came into effect earlier. Certain policies did not reappear in more recent documents, casting doubt on their validity. Furthermore, countries that recently produced HIV guidelines (South Africa: 2013 ART guidelines; Kenya: 2012 PMTCT guidelines) may appear to have more &#x02018;advanced&#x02019; policies than those currently in the process of updating their guidelines, including Malawi and the United Republic of Tanzania. Second, the extent to which all relevant policy indicators were captured is uncertain. Our systematic approach to develop tools and indicators attempted to minimize this, but there may be other factors that were missed. We did not investigate the broader national policy environment (<xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>). Factors such as national politics, laws and the criminal justice system, programme financing mechanisms and donor coordination have been shown to have strong influences on health seeking-behaviour and service response.<xref rid="R98" ref-type="bibr"><sup>98</sup></xref><sup>&#x02013;</sup><xref rid="R101" ref-type="bibr"><sup>101</sup></xref> Country-specific policy analyses will be needed to analyse these national influences in detail.</p><p>Interpreting these findings with regard to potential programme impact is challenging. In part this stems from the wide variation demonstrated in our analysis, but perhaps more importantly because policies are only the first step in programme delivery. Their effectiveness depends on service-level implementation, as well community-level factors.<xref rid="R99" ref-type="bibr"><sup>99</sup></xref><sup>,</sup><xref rid="R100" ref-type="bibr"><sup>100</sup></xref><sup>,</sup> Further analysis will examine how these different policies are implemented in ALPHA&#x02019;s network of health and demographic surveillance sites. This will allow us to assess whether policy translates into practice and whether practice exceeds stated policies, as often claimed by our key informants. International efforts to monitor policy implementation &#x02013; such as WHO&#x02019;s estimates on ART policy implementation<xref rid="R24" ref-type="bibr"><sup>24</sup></xref> &#x02013; are increasing and we hope that this review and its tools can support other efforts to track national policies.</p></sec></body><back><ack><title>Acknowledgements</title><p>We thank Masuma Mamdani, Sally Mtenga and Astha Ramaiya from the United Republic of Tanzania, Montserrat Fernandez from South Africa and Constance Nyamupaka and Simon Gregson from Zimbabwe.</p></ack><fn-group><title>Funding:</title><fn fn-type="supported-by"><p>This research was funded by a grant from the Bill &#x00026; Melinda Gates Foundation. Salaries of some individual authors are sponsored by institutional grants from: The Wellcome Trust, the Medical Research Council (United Kingdom) and the National Institutes of Health (United States of America).</p></fn></fn-group><fn-group><title>Competing interests:</title><fn fn-type="financial-disclosure"><p>None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="book"><source>Global update on HIV treatment 2013: results, impact and opportunities.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2013</year>.</mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Bor</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Herbst</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Newell</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>B&#x000e4;rnighausen</surname>
<given-names>T</given-names></string-name>. <article-title>Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment.</article-title>
<source>Science</source>. <year>2013</year>
<month>2</month>
<day>22</day>;<volume>339</volume>(<issue>6122</issue>):<fpage>961</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1126/science.1230413</pub-id><pub-id pub-id-type="pmid">23430655</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><string-name><surname>Chihana</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Floyd</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Molesworth</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Crampin</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Kayuni</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Price</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal>
<article-title>Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment.</article-title>
<source>Trop Med Int Health</source>. <year>2012</year>
<month>8</month>;<volume>17</volume>(<issue>8</issue>):<fpage>e74</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3156.2012.02929.x</pub-id><pub-id pub-id-type="pmid">22943382</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Floyd</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Marston</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Baisley</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Wringe</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Herbst</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Chihana</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>
<article-title>The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level&#x02013;a comparative analysis of data from four settings in Southern and East Africa.</article-title>
<source>Trop Med Int Health</source>. <year>2012</year>
<month>8</month>;<volume>17</volume>(<issue>8</issue>):<fpage>e84</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3156.2012.03032.x</pub-id><pub-id pub-id-type="pmid">22943383</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Jahn</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Floyd</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Crampin</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Mwaungulu</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Mvula</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Munthali</surname>
<given-names>F</given-names></string-name>, <etal>et al.</etal>
<article-title>Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi.</article-title>
<source>Lancet</source>. <year>2008</year>
<month>5</month>
<day>10</day>;<volume>371</volume>(<issue>9624</issue>):<fpage>1603</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(08)60693-5</pub-id><pub-id pub-id-type="pmid">18468544</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Kasamba</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Baisley</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Mayanja</surname>
<given-names>BN</given-names></string-name>, <string-name><surname>Maher</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Grosskurth</surname>
<given-names>H</given-names></string-name>. <article-title>The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: a longitudinal population-based study, 1999&#x02013;2009.</article-title>
<source>Trop Med Int Health</source>. <year>2012</year>
<month>8</month>;<volume>17</volume>(<issue>8</issue>):<fpage>e66</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3156.2012.02841.x</pub-id><pub-id pub-id-type="pmid">22943381</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Mayanja</surname>
<given-names>BN</given-names></string-name>, <string-name><surname>Baisley</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Nalweyiso</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Kibengo</surname>
<given-names>FM</given-names></string-name>, <string-name><surname>Mugisha</surname>
<given-names>JO</given-names></string-name>, <string-name><surname>Van der Paal</surname>
<given-names>L</given-names></string-name>, <etal>et al.</etal>
<article-title>Using verbal autopsy to assess the prevalence of HIV infection among deaths in the ART period in rural Uganda: a prospective cohort study, 2006&#x02013;2008.</article-title>
<source>Popul Health Metr</source>. <year>2011</year>;<volume>9</volume>(<issue>1</issue>):<fpage>36</fpage>. <pub-id pub-id-type="doi">10.1186/1478-7954-9-36</pub-id><pub-id pub-id-type="pmid">21816100</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Slaymaker</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Todd</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Marston</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Calvert</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Michael</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Nakiyingi-Miiro</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa.</article-title>
<source>Glob Health Action</source>. <year>2014</year>;<volume>7</volume>(<issue>0</issue>):<fpage>22789</fpage>. <pub-id pub-id-type="doi">10.3402/gha.v7.22789</pub-id><pub-id pub-id-type="pmid">24762982</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="book"><source>UNAIDS report on the global AIDS epidemic 2013.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>Joint United Nations Programme on HIV/AIDS</publisher-name>; <year>2013</year>.</mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Kranzer</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Govindasamy</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Ford</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Johnston</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Lawn</surname>
<given-names>SD</given-names></string-name>. <article-title>Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.</article-title>
<source>J Int AIDS Soc</source>. <year>2012</year>;<volume>15</volume>(<issue>2</issue>):<fpage>17383</fpage>. <pub-id pub-id-type="doi">10.7448/IAS.15.2.17383</pub-id><pub-id pub-id-type="pmid">23199799</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Glynn</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Calvert</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Price</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Chihana</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kachiwanda</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Mboma</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>
<article-title>Measuring causes of adult mortality in rural northern Malawi over a decade of change.</article-title>
<source>Glob Health Action</source>. <year>2014</year>;<volume>7</volume>(<issue>0</issue>):<fpage>23621</fpage>. <pub-id pub-id-type="doi">10.3402/gha.v7.23621</pub-id><pub-id pub-id-type="pmid">24802384</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>Kanjala</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Michael</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Todd</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Slaymaker</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Calvert</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Isingo</surname>
<given-names>R</given-names></string-name>, <etal>et al.</etal>
<article-title>Using HIV-attributable mortality to assess the impact of antiretroviral therapy on adult mortality in rural Tanzania.</article-title>
<source>Glob Health Action</source>. <year>2014</year>;<volume>7</volume>(<issue>0</issue>):<fpage>21865</fpage>. <pub-id pub-id-type="doi">10.3402/gha.v7.21865</pub-id><pub-id pub-id-type="pmid">24656167</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Maher</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Biraro</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hosegood</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Isingo</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Lutalo</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Mushati</surname>
<given-names>P</given-names></string-name>, <etal>et al.</etal>; <collab>Collaborators in ALPHA Network</collab>. <article-title>Translating global health research aims into action: the example of the ALPHA network.</article-title>
<source>Trop Med Int Health</source>. <year>2010</year>
<month>3</month>;<volume>15</volume>(<issue>3</issue>):<fpage>321</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3156.2009.02456.x</pub-id><pub-id pub-id-type="pmid">20070637</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>Masiira</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Baisley</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Mayanja</surname>
<given-names>BN</given-names></string-name>, <string-name><surname>Kazooba</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Maher</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Kaleebu</surname>
<given-names>P</given-names></string-name>. <article-title>Mortality and its predictors among antiretroviral therapy na&#x000ef;ve HIV-infected individuals with CD4 cell count &#x02265;350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda.</article-title>
<source>Glob Health Action</source>. <year>2014</year>;<volume>7</volume>(<issue>0</issue>):<fpage>21843</fpage>. <pub-id pub-id-type="doi">10.3402/gha.v7.21843</pub-id><pub-id pub-id-type="pmid">24433941</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="book"><source>The gap report.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>Joint United Nations Programme on HIV/AIDS</publisher-name>; <year>2014</year>.</mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Cherutich</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Kaiser</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Galbraith</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Williamson</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Shiraishi</surname>
<given-names>RW</given-names></string-name>, <string-name><surname>Ngare</surname>
<given-names>C</given-names></string-name>, <etal>et al.</etal>; <collab>KAIS Study Group</collab>. <article-title>Lack of knowledge of HIV status a major barrier to HIV prevention, care and treatment efforts in Kenya: results from a nationally representative study.</article-title>
<source>PLoS ONE</source>. <year>2012</year>;<volume>7</volume>(<issue>5</issue>):<fpage>e36797</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0036797</pub-id><pub-id pub-id-type="pmid">22574226</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="book"><source>Kenya AIDS indicator survey 2012 preliminary report.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>National AIDS and STI Control Programme, Ministry of Health Kenya</publisher-name>; <year>2013</year>.</mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="book"><source>2012 global AIDS response progress report: Malawi country report for 2010 and 2011.</source>
<publisher-loc>Lilongwe</publisher-loc>: <publisher-name>Malawi Government</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="book"><source>South African national HIV prevalence, incidence and behaviour survey, 2012.</source>
<publisher-loc>Cape Town</publisher-loc>: <publisher-name>Human Sciences Research Council</publisher-name>; <year>2014</year>.</mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="book"><source> 2011 Uganda AIDS indicator survey: key findings.</source>
<publisher-loc>Calverton</publisher-loc>: <publisher-name>Uganda Ministry of Health and ICF International</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="book"><source>HIV/AIDS and malaria indicator survey 2011&#x02013;12.</source>
<publisher-loc>Dar es Salaam</publisher-loc>: <publisher-name>Tanzania Commission for AIDS, Zanzibar AIDS Commission, National Bureau of Statistics, Office of the Chief Government Statistician and ICF International</publisher-name>; <year>2013</year>.</mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="book"><source>Zimbabwe demographic and health survey 2010&#x02013;2011.</source>
<publisher-loc>Calverton</publisher-loc>: <publisher-name>Zimbabwe National Statistics Agency and ICF International</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="book"><source>World health statistics 2013.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2013</year>.</mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="book"><collab>Global update on the health sector response to HIV</collab>, <source>2014. Geneva:</source>
<publisher-name>World Health Organization</publisher-name>; <year>2014</year>.</mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="book"><source>A public health approach for scaling up antiretroviral treatment: a toolkit for program managers.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2003</year>.</mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="book"><source>Presidential declaration. Nairobi, Kenya.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Executive Office of the President</publisher-name>; <year>2006</year>.</mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="book"><source>HCT scale-up plan 2004&#x02013;2005: The 2 year plan to scale up counselling and HIV testing services in Malawi. </source><publisher-loc>Lilongwe</publisher-loc>: <publisher-name>Malawi Ministry of Health</publisher-name>; <year>2004</year>.</mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="book"><source>Country progress report on the declaration of commitment on HIV/AIDS.</source>
<publisher-loc>Pretoria</publisher-loc>: <publisher-name>South Africa Department of Health</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="book"><source>Uganda national policy guidelines for HIV counseling and testing. Kampala.</source>
<publisher-loc>Kampala</publisher-loc>: <publisher-name>Uganda Ministry of Health</publisher-name>; <year>2005</year>.</mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="book"><source>National guidelines for voluntary counseling and testing.</source>
<publisher-loc>Dar es Salaam</publisher-loc>: <publisher-name>Tanzanian National AIDS Control Program</publisher-name>; <year>2005</year>.</mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="book"><source>Review of hospital fees and charges.</source>
<publisher-loc>Harare</publisher-loc>: <publisher-name>Zimbabwe Ministry of Health and Child Welfare</publisher-name>; <year>2007</year>.</mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="book"><source>Rapid HIV tests: guidelines for use in HIV testing and counselling services in resource-constrained settings.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2004</year>.</mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="book"><source>Guidelines for HIV testing and counselling, Kenya.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>National AIDS and STI Control Programme</publisher-name>; <year>2008</year>.</mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="book"><source>The 5-year plan to scale up HCT services in Malawi 2006&#x02013;2010.</source>
<publisher-loc>Lilongwe</publisher-loc>: <publisher-name>Malawi Ministry of Health</publisher-name>; <year>2006</year>.</mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="book"><source>HIV counselling and testing (HCT) policy guidelines.</source>
<publisher-loc>Pretoria</publisher-loc>: <publisher-name>South Africa Department of Health</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="book"><source>Uganda HIV counselling and testing policy.</source>
<publisher-loc>Kampala</publisher-loc>: <publisher-name>Uganda Ministry of Health</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="book"><source>Guidelines for HIV testing and counseling in clinical settings.</source>
<publisher-loc>Dar es Salaam</publisher-loc>: <publisher-name>Tanzanian National AIDS Control Program</publisher-name>; <year>2007</year>.</mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="book"><source>Zimbabwe national guidelines on HIV testing and counselling.</source>
<publisher-loc>Harare</publisher-loc>: <publisher-name>Zimbabwe Ministry of Health and Child Welfare</publisher-name>; <year>2005</year>.</mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="book"><source>National HIV testing and counselling training course for health workers.</source>
<publisher-loc>Harare</publisher-loc>: <publisher-name>Zimbabwe Ministry of Health and Child Welfare</publisher-name>; <year>2007</year>.</mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="book"><source>National guidelines for HIV/STI programs for sex workers.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Kenya Ministry of Public Health and Sanitation</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="book"><source>Guidance on provider-initiated HIV testing and counselling in health facilities.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2007</year>.</mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="book"><source>Guidelines for HCT.</source>
<edition>3rd ed.</edition>
<publisher-loc>Lilongwe</publisher-loc>: <publisher-name>Malawi Ministry of Health</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="other">Children&#x02019;s Act 38, Section 130. South Africa; 2005.</mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="book"><source>Operational manual for community-based HIV testing and counselling.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Kenya National AIDS and STI Control Programme (Kenya)</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="book"><source>National quality management guidance framework for HIV testing and counseling.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Kenya National AIDS and STI Control Programme</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="book"><source>Patient monitoring guidelines for HIV care and antiretroviral therapy (ART).</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2006</year>.</mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="book"><source>Operational manual for implementing provider-initiated HIV testing and counseling in clinical settings.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Kenya National AIDS and STI Control Programme</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="book"><source>Repeat and re-testing guidance.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Kenya National AIDS and STI Control Programme</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="book"><source>Delivering HIV test results and messages for re-testing and counselling in adults.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R50"><label>50</label><mixed-citation publication-type="book"><source>National recommendations for PMTCT of HIV, IYCF and ART for children, adults &#x00026; adolescents.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Kenya Ministry of Public Health and Sanitation &#x00026; Medics Management Services</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R51"><label>51</label><mixed-citation publication-type="book"><source>Prevention of mother to child transmission of HIV and paediatric HIV care guidelines.</source>
<publisher-loc>Lilongwe</publisher-loc>: <publisher-name>Malawi Ministry of Health</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R52"><label>52</label><mixed-citation publication-type="book"><source>Clinical guidelines: PMTCT (Prevention of mother to child transmission).</source>
<publisher-loc>Pretoria</publisher-loc>: <publisher-name>South Africa Department of Health</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R53"><label>53</label><mixed-citation publication-type="book"><source>The integrated national guidelines on antiretroviral therapy, prevention of mother to child transmission of HIV and infant &#x00026; young child feeding.</source>
<edition>1st ed.</edition>
<publisher-loc>Kampala</publisher-loc>: <publisher-name>Uganda Ministry of Health</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="R54"><label>54</label><mixed-citation publication-type="book"><source>The right to know: new approaches to HIV testing and counselling.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2003</year>.</mixed-citation></ref><ref id="R55"><label>55</label><mixed-citation publication-type="book"><source>Scaling-up HIV testing and counselling services: a toolkit for programme managers.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2003</year>.</mixed-citation></ref><ref id="R56"><label>56</label><mixed-citation publication-type="book"><source>National antiretroviral treatment and care guidelines for adults and children.</source>
<edition>1st ed.</edition>
<publisher-loc>Kampala</publisher-loc>: <publisher-name>Uganda Ministry of Health</publisher-name>; <year>2003</year>.</mixed-citation></ref><ref id="R57"><label>57</label><mixed-citation publication-type="other">Constitution of the Republic of South Africa Act; 1996.</mixed-citation></ref><ref id="R58"><label>58</label><mixed-citation publication-type="book"><source>Uganda antiretroviral treatment policy.</source>
<edition>2nd ed.</edition>
<publisher-loc>Kampala</publisher-loc>: <publisher-name>Uganda Ministry of Health</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="R59"><label>59</label><mixed-citation publication-type="book"><source>National health policy.</source>
<publisher-loc>Dar es Salaam</publisher-loc>: <publisher-name>United Republic of Tanzania Ministry of Health and Social Welfare</publisher-name>; <year>2007</year>.</mixed-citation></ref><ref id="R60"><label>60</label><mixed-citation publication-type="book"><source>Guidelines for antiretroviral therapy in Kenya.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Kenya National AIDS and STI Control Programme</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="R61"><label>61</label><mixed-citation publication-type="book"><source>Guidelines for the use of ART in Malawi.</source>
<edition>2nd ed.</edition>
<publisher-loc>Lilongwe</publisher-loc>: <publisher-name>Malawi Ministry of Health</publisher-name>; <year>2006</year>.</mixed-citation></ref><ref id="R62"><label>62</label><mixed-citation publication-type="book"><source>The South Africa antiretroviral treatment guidelines.</source>
<publisher-loc>Pretoria</publisher-loc>: <publisher-name>South Africa Department of Health</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R63"><label>63</label><mixed-citation publication-type="book"><source>Antiretroviral drugs for treating pregnant women and preventing HIV Infection in infants.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R64"><label>64</label><mixed-citation publication-type="book"><source>Guidelines for PMTCT of HIV/AIDS in Kenya.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Kenya National AIDS and STI Control Programme</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R65"><label>65</label><mixed-citation publication-type="book"><source>National guidelines for comprehensive care of prevention of mother-to-child transmission of HIV.</source>
<edition>3rd ed.</edition>
<publisher-loc>Dar es Salaam</publisher-loc>: <publisher-name>Tanzanian Ministry of Health and Social Welfare</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R66"><label>66</label><mixed-citation publication-type="book"><source>Essential medicines list and standard treatment guidelines for Zimbabwe.</source>
<edition>6th ed.</edition>
<publisher-loc>Harare</publisher-loc>: <publisher-name>Zimbabwe Ministry of Health and Child Welfare</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="R67"><label>67</label><mixed-citation publication-type="book"><source>National ART guidelines.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Kenya National AIDS and STI Control Programme</publisher-name>; <year>2005</year>.</mixed-citation></ref><ref id="R68"><label>68</label><mixed-citation publication-type="book"><source>Guidelines for the use of ART in Malawi.</source>
<edition>3rd ed.</edition>
<publisher-loc>Lilongwe</publisher-loc>: <publisher-name>Malawi Ministry of Health</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R69"><label>69</label><mixed-citation publication-type="book"><source>National guidelines for the clinical management of HIV and AIDS.</source>
<edition>2nd ed.</edition>
<publisher-loc>Dar es Salaam</publisher-loc>: <publisher-name>Tanzanian National AIDS Control Program</publisher-name>; <year>2005</year>.</mixed-citation></ref><ref id="R70"><label>70</label><mixed-citation publication-type="book"><source>Guidelines for antiretroviral therapy in Zimbabwe.</source>
<publisher-loc>Harare</publisher-loc>: <publisher-name>Zimbabwe Ministry of Health and Child Welfare</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R71"><label>71</label><mixed-citation publication-type="book"><source>National guidelines for home based care services.</source>
<publisher-loc>Dar es Salaam</publisher-loc>: <publisher-name>Tanzanian National AIDS Control Program</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R72"><label>72</label><mixed-citation publication-type="book"><source>Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2006</year>.</mixed-citation></ref><ref id="R73"><label>73</label><mixed-citation publication-type="book"><source>Clinical management of HIV in children and adults: Malawi integrated guidelines.</source>
<publisher-loc>Lilongwe</publisher-loc>: <publisher-name>Malawi Ministry of Health</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="R74"><label>74</label><mixed-citation publication-type="book"><source>Policy for reduction of the mother-to-child HIV transmission in Uganda.</source>
<publisher-loc>Kampala</publisher-loc>: <publisher-name>Uganda Ministry of Health</publisher-name>; <year>2003</year>.</mixed-citation></ref><ref id="R75"><label>75</label><mixed-citation publication-type="book"><source>National antiretroviral treatment and care guidelines for adults, adolescents, and children.</source>
<edition>3rd ed.</edition>
<publisher-loc>Kampala</publisher-loc>: <publisher-name>Uganda Ministry of Health</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="R76"><label>76</label><mixed-citation publication-type="book"><source>National guidelines for the clinical management of HIV and AIDS.</source>
<edition>3rd ed.</edition>
<publisher-loc>Dar es Salaam</publisher-loc>: <publisher-name>Tanzanian National AIDS Control Program</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="R77"><label>77</label><mixed-citation publication-type="book"><source>HIV and AIDS treatment and care programme documents and tools in Zimbabwe.</source>
<publisher-loc>Harare</publisher-loc>: <publisher-name>Zimbabwe Ministry of Health and Child Welfare</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R78"><label>78</label><mixed-citation publication-type="book"><source>Program update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R79"><label>79</label><mixed-citation publication-type="book"><source>Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="R80"><label>80</label><mixed-citation publication-type="book"><source>Kenya national clinical manual for ART providers.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Kenya National AIDS and STI Control Programme</publisher-name>; <year>2007</year>.</mixed-citation></ref><ref id="R81"><label>81</label><mixed-citation publication-type="book"><source>Guidelines for the use of ART in Malawi.</source>
<edition>1st ed.</edition>
<publisher-loc>Lilongwe</publisher-loc>: <publisher-name>Malawi Ministry of Health</publisher-name>; <year>2003</year>.</mixed-citation></ref><ref id="R82"><label>82</label><mixed-citation publication-type="book"><source>The South Africa antiretroviral treatment guidelines.</source>
<publisher-loc>Pretoria</publisher-loc>: <publisher-name>South Africa Department of Health</publisher-name>; <year>2013</year>.</mixed-citation></ref><ref id="R83"><label>83</label><mixed-citation publication-type="book"><source>National guidelines for the clinical management of HIV and AIDS.</source>
<edition>4th ed.</edition>
<publisher-loc>Dar es Salaam</publisher-loc>: <publisher-name>Tanzanian National AIDS Control Program</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R84"><label>84</label><mixed-citation publication-type="book"><source>Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2013</year>.</mixed-citation></ref><ref id="R85"><label>85</label><mixed-citation publication-type="book"><source>Task shifting: global recommendations and guidelines.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2008</year>.</mixed-citation></ref><ref id="R86"><label>86</label><mixed-citation publication-type="book"><source>Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R87"><label>87</label><mixed-citation publication-type="book"><source>HIV/AIDS decentralization guidelines.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Kenya Ministry of Public Health and Sanitation</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="R88"><label>88</label><mixed-citation publication-type="book"><source>National antiretroviral treatment and care guidelines for adults, adolescents, and children.</source>
<edition>2nd ed.</edition>
<publisher-loc>Kampala</publisher-loc>: <publisher-name>Uganda Ministry of Health</publisher-name>; <year>2008</year>.</mixed-citation></ref><ref id="R89"><label>89</label><mixed-citation publication-type="book"><source>Integrated management of adult and adolescent illness guidelines.</source>
<publisher-loc>Harare</publisher-loc>: <publisher-name>Zimbabwe Ministry of Health and Child Welfare</publisher-name>; <year>2006</year>.</mixed-citation></ref><ref id="R90"><label>90</label><mixed-citation publication-type="book"><source>National community and home based care guidelines.</source>
<publisher-loc>Harare</publisher-loc>: <publisher-name>Zimbabwe Ministry of Health and Child Welfare</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="R91"><label>91</label><mixed-citation publication-type="book"><source>Harmonized indicator manual for the HIV program.</source>
<publisher-loc>Nairobi</publisher-loc>: <publisher-name>Kenya National AIDS and STI Control Programme</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R92"><label>92</label><mixed-citation publication-type="book"><source>Chronic HIV care pre-ART register.</source>
<publisher-loc>Harare</publisher-loc>: <publisher-name>Zimbabwe Ministry of Health and Child Welfare</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R93"><label>93</label><mixed-citation publication-type="book"><source>Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="R94"><label>94</label><mixed-citation publication-type="book"><source>National policy guidelines for TB/HIV collaborative activities in Uganda.</source>
<publisher-loc>Kampala</publisher-loc>: <publisher-name>Uganda Ministry of Health</publisher-name>; <year>2006</year>.</mixed-citation></ref><ref id="R95"><label>95</label><mixed-citation publication-type="book"><source>Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2006</year>.</mixed-citation></ref><ref id="R96"><label>96</label><mixed-citation publication-type="book"><source>Home based care policy guidelines for HIV/AIDS.</source>
<publisher-loc>Kampala</publisher-loc>: <publisher-name>Uganda Ministry of Health</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="R97"><label>97</label><mixed-citation publication-type="journal"><string-name><surname>Chang</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Crane</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mina</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Post</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Cameron</surname>
<given-names>BA</given-names></string-name>, <etal>et al.</etal>
<article-title>HIV and co-infections.</article-title>
<source>Immunol Rev</source>. <year>2013</year>
<month>7</month>;<volume>254</volume>(<issue>1</issue>):<fpage>114</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12063</pub-id><pub-id pub-id-type="pmid">23772618</pub-id></mixed-citation></ref><ref id="R98"><label>98</label><mixed-citation publication-type="journal"><string-name><surname>Amon</surname>
<given-names>JJ</given-names></string-name>. <article-title>The political epidemiology of HIV.</article-title>
<source>J Int AIDS Soc</source>. <year>2014</year>;<volume>17</volume>(<issue>1</issue>):<fpage>19327</fpage>. <pub-id pub-id-type="doi">10.7448/IAS.17.1.19327</pub-id><pub-id pub-id-type="pmid">25059653</pub-id></mixed-citation></ref><ref id="R99"><label>99</label><mixed-citation publication-type="journal"><string-name><surname>Baral</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Holland</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Shannon</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Logie</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Semugoma</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Sithole</surname>
<given-names>B</given-names></string-name>, <etal>et al.</etal>
<article-title>Enhancing benefits or increasing harms: community responses for HIV among men who have sex with men, transgender women, female sex workers, and people who inject drugs.</article-title>
<source>J Acquir Immune Defic Syndr</source>. <year>2014</year>
<month>8</month>
<day>15</day>;<volume>66</volume>
<issue>Suppl 3</issue>:<fpage>S319</fpage>&#x02013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1097/QAI.0000000000000233</pub-id><pub-id pub-id-type="pmid">25007203</pub-id></mixed-citation></ref><ref id="R100"><label>100</label><mixed-citation publication-type="journal"><string-name><surname>Seeley</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Watts</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Kippax</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Russell</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Heise</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Whiteside</surname>
<given-names>A</given-names></string-name>. <article-title>Addressing the structural drivers of HIV: a luxury or necessity for programmes?</article-title>
<source>J Int AIDS Soc</source>. <year>2012</year>;<volume>15</volume>(<issue>3</issue>) <supplement>Suppl 1</supplement>:<fpage>1</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">22905346</pub-id></mixed-citation></ref><ref id="R101"><label>101</label><mixed-citation publication-type="book"><source>Human rights and the law.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>Joint United Nations Programme on HIV/AIDS</publisher-name>; <year>2012</year>.</mixed-citation></ref></ref-list></back></article>